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 Oxidative stress, caused by reactive oxygen species (ROS) such as hydrogen 
peroxide, can have harmful effects on important cellular components and processes which 
can lead to cell death. Cells have evolved extensive protein and non-protein antioxidant 
molecules to deal with hydrogen peroxide but it is now clear that hydrogen peroxide is also 
important signal molecule. It is not fully understood how cells maintain the balance between 
hydrogen peroxide detoxification and signal transduction. Peroxiredoxins are a ubiquitous 
family of antioxidant proteins that are the primary reductants of hydrogen peroxide and 
appear to be key molecules in mediating this balance. Using catalytic cysteines, 
peroxiredoxins reduce hydrogen peroxide and other ROS and in turn are reduced by 
thioredoxin and thioredoxin reductase. This coupled set of reactions collectively constitute 
the peroxiredoxin system and its precise role in redox signalling could be established using 
systems biology studies. However, there are some discrepancies on how peroxiredoxins 
should be described in these studies as three distinct kinetic models have been proposed for 
peroxiredoxin activity: the ping-pong enzyme, redox couple monomer and redox couple 
homodimer models. Further, different rate constants for hydrogen peroxide reduction by 
peroxiredoxins have been reported using steady state and competition assays and it is not 
clear which of these parameters should be used in computational models. In order to resolve 
these discrepancies, the three proposed peroxiredoxin kinetic models were simulated with 
core parameters and showed different responses to parameter changes. Computational 
modelling with in vitro datasets confirmed this result and also showed that many of the 
reported peroxiredoxin kinetic parameters have limited predictive value. Thus, the kinetic 
models for peroxiredoxin activity cannot be used interchangeably and computational models 
based on the reported peroxiredoxin kinetic parameters for hydrogen peroxide reduction 
should be viewed with caution. To confirm this result, the cytosolic peroxiredoxin thiol-
specific antioxidant 1 (TSA1) from Saccharomyces cerevisiae was cloned, expressed and 
purified for in vitro analysis of this system. Data fitting of the peroxiredoxin kinetic models 
determined parameters that were able to predict independent datasets with increasing 
thioredoxin and peroxiredoxin concentrations using the ping-pong enzyme and redox couple 
monomer models but the redox couple homodimer model was unable to fit these datasets. A 
complex flux control pattern was also determined for the fitted models and whole system 
fitting to in vitro datasets is proposed to be a more accurate method for parameter 
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Aerobic life forms have evolved to utilise oxygen for respiration and other metabolic 
processes (Apel and Hirt, 2004; Halliwell, 2006; D'autreaux and Toledano, 2007; Weidinger 
and Kozlov, 2015). However, incomplete reduction of oxygen generates reactive free radical 
and non-radical species (ROS), such as the hydroxyl radical (OH˙) and hydrogen peroxide 
which can damage lipids, protein and DNA (Figure 1.1, Apel and Hirt, 2004; D'autreaux and 
Toledano, 2007; Pham-Huy et al., 2008a). Cells have evolved extensive protein and non-
protein antioxidant systems to tackle ROS and maintain cellular redox homeostasis and an 
imbalance between ROS production and detoxification was proposed to be a central feature 
of many diseases including cancer (Schumacker, 2006; Liou and Storz, 2010) and aging 
(Liochev, 2013). Despite their toxicity, ROS have recently been identified as important 
signalling molecules in spite of these antioxidant systems and thus, the simple idea of a redox 
balance in oxidative stress is being modified (D'autreaux and Toledano, 2007; Veal et al., 
2007; Pham-Huy et al., 2008a; Weidinger and Kozlov, 2015). The complexity of redox 
homeostasis and the necessity for low levels of ROS has also been shown by the failure of 
antioxidant therapies (Firuzi et al., 2011) which may actually be detrimental and accelerate 
disease progression (Ristow et al., 2009; Sayin et al., 2014).  
 
Figure 1.1 Ground state oxygen (O2) is reduced sequentially through energy transfer and 
electron transfer reactions to more reactive species such as the highly reactive hydroxyl 
radical (OH˙) (Taken from Apel and Hirt, 2004).  
When compared to other ROS, hydrogen peroxide is less reactive but relatively stable 
with a half-life of ~10-3 s and appears to play a role in a number of important cellular 
processes such as activation of mitogen-activated protein kinases (MAPK) (Bhat and Zhang, 
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1999; Park et al., 2005) and redox-dependent signalling (D'autreaux and Toledano, 2007; 
Veal et al., 2007; Veal and Day, 2011; Boronat et al., 2014). Intracellular hydrogen peroxide 
production results from oxidative phosphorylation in the mitochondria but can be specifically 
catalysed by a number of processes including growth factor stimulation of the membrane 
protein NADPH oxidase (Nox) (Figure 1.2, Finkel, 2011; Veal et al., 2007). Hydrogen 
peroxide diffusion across membranes can also occur via aquaporins (Bienert et al., 2006). 
Excessive hydrogen peroxide levels can lead to oxidative stress and causes damage to DNA 
(see for example Driessens et al., 2009), proteins (see for example Cabiscol et al., 2000) and 
lipids (see for example Siddique et al., 2012). It is not clear how cells mediate the balance 
between hydrogen peroxide detoxification and hydrogen peroxide-dependent signalling.  
 
Figure 1.2 Intracellular and extracellular processes can result in hydrogen peroxide 
production. Growth factors and cytokines can purposefully stimulate intracellular hydrogen 
peroxide production. Oxygen diffusion into cells and partial oxygen reduction in 
mitochondria creates highly reactive superoxide molecules that are catalysed by superoxide 
dismutases into a less harmful hydrogen peroxide molecule. Phagocytic immune cell activity 
can produce hydrogen peroxide, which then diffuses across membranes into other cells 
(Taken from Veal et al., 2007).  
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1.2 Cellular defences against hydrogen peroxide 
Antioxidant activity can be classed as enzymatic and non-enzymatic (Young and 
Woodside, 2001; Pham-Huy et al., 2008b). Non-enzymatic antioxidants include ascorbate 
and glutathione which are not considered primary hydrogen peroxide scavengers because of 
their low reactivity (Winterbourn, 2008). Catalases are one of the most well-studied 
enzymatic antioxidants and were long thought to be the most important catalysts for 
hydrogen peroxide detoxification (Masuoka et al., 1996; Chelikani et al., 2004) although it 
now recognised that they are more effective at relatively high hydrogen peroxide 
concentrations because they use a disproportion reaction mechanism (Mishra and Imlay, 
2012). Peroxiredoxins are considered the primary reductants of hydrogen peroxide at the 
prevailing intracellular hydrogen peroxide concentrations. The cytosolic peroxiredoxin 
known as thiol-specific antioxidant 1 (TSA1) was first discovered in Saccharomyces 
cerevisiae (Chae and Rhee, 1994) and was the focus of this study.  
 
1.2.1 Peroxiredoxins are part of the thioredoxin antioxidant superfamily 
The redoxins, thioredoxin, glutaredoxin and peroxiredoxin, are members of the highly 
conserved thioredoxin antioxidant protein family and all contain a characteristic thioredoxin-
fold in their structure (Martin, 1995). Thioredoxins are small, heat stable proteins that contain 
a highly conserved dithiol active site motif (Arner and Holmgren, 2000) and were first 
discovered for their role as electron donors to ribonucleotide reductase (RNR) in 
deoxyribonucleotide synthesis (Laurent et al., 1964). In addition to RNR, thioredoxins reduce 
a number of protein and non-protein targets including peroxiredoxins and are subsequently 
reduced by thioredoxin reductase and β-nicotinamide adenine dinucleotide phosphate 
(NADPH) (Figure 1.3). Thioredoxins are also involved in redox signalling processes during 
non-stress conditions by inactivating apoptosis signal-regulating kinase-1 (ASK1) (Liu et al., 
2006), while during oxidative stress, thioredoxins interact with oxidative stress repair 
proteins such as methionine sulfoxide reductase A (MsrA) to facilitate repair (Olry et al., 
2004). 
 
Glutaredoxins are structurally similar to thioredoxins as they are also small heat-stable 
proteins and are classed as monothiol or dithiol based on the number of cysteine residues in 
their active site (Holmgren, 1988; Lillig et al., 2008). Although functionally similar to 
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thioredoxin, glutaredoxins uniquely interact with glutathione (GSH) via glutathione reductase 
to alter the activity of specific proteins through the glutathionylation/deglutathionylation 
cycle (Mieyal et al., 2008; Grek et al., 2013).  
 
Figure 1.3 NADPH acts as an electron source for the thioredoxin system (Trx) via 
thioredoxin reductase (TrxR) and the glutaredoxin system (Grx) via glutaredoxin reductase 
(GR) and glutathione (GSH). Reduced thioredoxin and glutaredoxin then reduce a number of 
protein targets such as peroxiredoxins (Taken from Hanschmann et al., 2013).  
Peroxiredoxins are classed as 1-Cys or 2-Cys, depending on the number of highly 
conserved active site cysteine residues directly involved in their action (Wood et al., 2003b; 
Hall et al., 2009). As the primary cellular hydrogen peroxide reductants, peroxiredoxins play 
a key role in maintaining redox balance, in oxidative stress defence and can also reduce 
reactive nitrogen species (RNS) (Hall et al., 2009; Poole et al., 2011; Perkins et al., 2015). 
Deletions of different peroxiredoxin genes have also revealed their role in a number of 
important cellular processes including regulating DNA damage checkpoints and maintaining 
genome stability (Chabes et al., 2003; Iraqui et al., 2009).  
Although long considered enzymes in their own right, there is growing acceptance that 
redoxin activity and regulation depends on the kinetic linkages to their cognate systems 
(Figure 1.3). For example, in the peroxiredoxin system, reducing equivalents from NADPH 
are transferred to thioredoxin via thioredoxin reductase and in turn thioredoxin reduces 
peroxiredoxin which can than reduce a range of peroxide substrates (Chae et al., 1994a). 
Disruption of thioredoxin reductase or thioredoxin can therefore effect peroxiredoxin activity 
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in vivo (Trotter et al., 2008; Ragu et al., 2014). The activity and functions of peroxiredoxins 
will be discussed below. 
1.3 Peroxiredoxin kinetic mechanism and structure 
As previously mentioned, the main role of peroxiredoxins is hydrogen peroxide 
degradation at physiological levels of hydrogen peroxide to maintain redox homeostasis. In 
addition, at high hydrogen peroxide levels (>1 mM), peroxiredoxins can become inactivated 
by hyperoxidation and undergo structural and functional changes to form high molecular 
weight super chaperones to defend against oxidative stress (Lim et al., 2008; König et al., 
2013; Radjainia et al., 2015).  
Peroxiredoxins have also been found to be key mediators in redox signalling processes 
(Brown et al., 2013; Park et al., 2014; Sobotta et al., 2015) and have also been linked with a 
number of pathologies including malaria (Kawazu et al., 2008), tuberculosis (see for example 
Koshkin et al., 2004) and cancer (see for example Wang et al., 2005). Understanding the role 
of peroxiredoxins under normal and pathogenic conditions may therefore provide insight into 
redox signalling and pathologies associated with peroxiredoxin activity. The multifunctional 
activity of peroxiredoxins will be discussed in greater detail below.  
1.3.1 Hydrogen peroxide reduction by peroxiredoxins 
 
 At physiological hydrogen peroxide concentrations (<1 mM), the peroxidatic cysteine 
residue of peroxiredoxin will form a sulfenic intermediate (-SOH) whilst reducing hydrogen 
peroxide to water (Figure 1.4). This cysteine residue will then form a disulfide bond with a 
resolving cysteine, before being reduced by thioredoxin to its active reduced form (-SH) 
(Wood et al., 2003a).  
 
In eukaryotic cells, peroxiredoxin activity is directly regulated by the prevailing 
hydrogen peroxide concentration (Figure 1.4). Eukaryotic peroxiredoxins have two modes of 
action based on ‘normal’ physiological or stress-inducing hydrogen peroxide concentrations 
(>1 mM) (Day et al., 2012; Karplus and Poole, 2012). Disulfide bond formation between the 
peroxidatic cysteine and the resolving cysteine is a relatively slow reaction and at high 
hydrogen peroxide concentrations, in eukaryotic and some bacterial peroxiredoxins, the 
sulfenic acid can instead further react with hydrogen peroxide to form a hyperoxidised 
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sulfinic acid (-SO2H). Efficient peroxiredoxin hyperoxidation by hydrogen peroxide has been 
reported to occur only in the presence of a recycling system (Cao et al., 2014) and the 
resulting sulfinic acid cannot be regenerated by thioredoxin and instead requires an ATP-
dependent reaction with sulfiredoxin (Biteau et al., 2003). A further oxidation reaction of the 
sulfinic acid with hydrogen peroxide can also occur and irreversibly produces a sulfonic acid, 
which cannot be reduced (-SO3H) (Lim et al., 2008). 
 
Figure 1.4 The catalytic cycle of a typical 2-Cys (A), atypical 2-Cys (B) and 1-Cys 
peroxiredoxin (C) which are normally resolved by the thioredoxin 
(Trx/TrxR/NADPH)/glutaredoxin (GSH/GST) system. Sulfiredoxin (SRX) may also be 
required to regenerate mammalian peroxiredoxins if they are hyperoxidised by high 
hydrogen peroxide concentrations (Taken from Rhee et al., 2012).  
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1.3.2 Structural features of peroxiredoxins 
2-Cys peroxiredoxins can be subdivided into two classes; typical and atypical (Wood 
et al., 2003a). Most peroxiredoxins are typical 2-Cys and form homodimers in a head-tail 
arrangement with the peroxidatic and resolving cysteines on adjacent subunits. Atypical 
peroxiredoxins, such as mammalian Prdx V, are active as monomers and the peroxidatic and 
resolving cysteines are present on the same subunit (Seo et al., 2000). Unlike thioredoxins 
and glutaredoxins, these peroxiredoxins can assemble into high molecular weight structures 
which have functional consequences for their activity.  
Peroxiredoxins have typically been observed as decamers in their reduced form in 
vivo (De Oliveira et al., 2007; Park et al., 2011; Tairum et al., 2012) and can dissociate into 
dimers upon oxidation (Parsonage et al., 2005; Barranco-Medina et al., 2009; Cao et al., 
2011). At high hydrogen peroxide concentrations, further oxidation to a hyperoxidised state 
yields monomers which can assemble into a dodecamer with chaperone activity (Jang et al., 
2004; Lim et al., 2008; König et al., 2013). Other factors affecting the oligomeric state of 
peroxiredoxins include pH (Morais et al., 2015), protein and salt concentration (Matsumura 
et al., 2008).  
1.4 The role of peroxiredoxins in hydrogen peroxide redox signalling 
Eukaryotic organisms have evolved to use hydrogen peroxide as an essential signal 
molecule by careful regulation of its production and localization (Veal et al., 2007). 
Regulation of antioxidant activity is necessary to allow hydrogen peroxide to accumulate and 
function as a signal molecule but not accumulate to levels that can damage cellular 
components. Specific roles of peroxiredoxins in signalling processes will be discussed below. 
1.4.1 Hyperoxidation causes inactivation of peroxiredoxins 
 
There are two proposed biological explanations for why hyperoxidation occurs. 
Firstly, in the ‘floodgate’ hypothesis, hydrogen peroxide can accumulate by temporarily 
limiting peroxiredoxin activity through hyperoxidation, allowing for redox signalling (Wood 
et al., 2003a). The second explanation suggests that the pool of reduced thioredoxin within 
the cell is preserved by peroxiredoxin hyperoxidation and is therefore available for other 
thioredoxin-dependent targets, such as MsrA, to repair proteins that may have been damaged 
by oxidative stress (Poole, 2005; Day et al., 2012). Thus, the peroxiredoxin system is 
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‘sacrificed’ by inactivation in order to allow cells to recover from oxidative-stress induced 
damage. Collectively, these results suggest that the combined dynamics of the thioredoxin 
and peroxiredoxin systems result in a complex and differentiated oxidative stress response. 
 
Hyperoxidised peroxiredoxins can also promote the repair of cellular proteins and 
structures damaged by oxidative stress by combining to form multimeric structures, typically 
dodecamers, which have a 4-fold increase in chaperone activity compared to reduced 
peroxiredoxin (Trotter et al., 2008). These super chaperones are ribosome associated and help 
prevent protein misfolding and aggregation by binding to naked hydrophobic sites of 
unfolded proteins (Jang et al., 2004; Trotter et al., 2008), allowing cells to recover damaged 
structures found on ribosomes or protecting newly synthesized proteins during oxidative 
stress. Some peroxiredoxins are more susceptible to hyperoxidation and therefore it would 
seem that these peroxiredoxins play more of a protective role within the cell than other 
isoforms (Peskin et al., 2013). For example, mammalian peroxiredoxins are relatively more 
susceptible to hyperoxidation than prokaryotic peroxiredoxins which seems appropriate as the 
levels of hydrogen peroxide that mammalian peroxiredoxins are subjected are different to 
those of free living bacteria and yeasts. Irreversibly hyperoxidised peroxiredoxins, which 
have a sulfonic acid peroxidatic cysteine (-SO3H) permanently lose their peroxidase activity 
but have continued chaperone activity (Lim et al., 2008). It has been suggested that 
measurement of this irreversibly hyperoxidised form of peroxiredoxin could be used as a 
marker for oxidative stress (Poynton and Hampton, 2014).  
1.4.2 Inactivation of peroxiredoxins by phosphorylation allows an accumulation of 
hydrogen peroxide for signalling 
Although inactivation of peroxiredoxins can occur by hyperoxidation, inactivation by 
phosphorylation has also been observed in some peroxiredoxins (Woo et al., 2010). The 
mammalian peroxiredoxin PrxI, when membrane associated, was found to be phosphorylated 
on its Tyr194 residue and inactivated when the cell was stimulated by growth factors or 
immune receptors. Cellular hydrogen peroxide concentrations were then able to accumulate 
in this region and cause activation of phosphokinase signal pathways as hydrogen peroxide 
oxidizes redox-sensitive phosphatases (Figure 1.5, Finkel, 2011). Outside the periplasmic 
region, peroxiredoxins are still active and regulate hydrogen peroxide levels (Finkel, 2011; 




Figure 1.5 A growth factor (GF) signal is transmitted that inactivates peroxiredoxins (Prx1) 
by phosphorylation, allowing the intracellular hydrogen peroxide concentration to increase. 
Hydrogen peroxide then inactivates phosphatases (PTP), allowing for kinase-dependent 
signalling (Taken from Finkel, 2011).  
1.4.3 Propagation of a redox signal by peroxiredoxin activity 
 
 Some peroxiredoxins can directly transmit redox signals by thiol-disulfide exchange. 
During their catalytic cycle, these peroxiredoxins become oxidised and in turn oxidise 
transcription facts such as YAP1 in budding yeast (Veal et al., 2003; Tachibana et al., 2009), 
STAT3 in mammalian cells (Sobotta et al., 2015) and PAP1 in fission yeast (Brown et al., 
2013). To emphasise this function, the PAP1 system will be discussed in more detail below. 
PAP1 is present in the cytosol in a reduced state under normoxic conditions (Brown et 
al., 2013). If the extracellular hydrogen peroxide concentration is increased to 0.2 mM, the 
peroxiredoxin Tpx1 becomes oxidised and in turn oxidises PAP1, which accumulates in the 
nucleus and induces gene expression. PAP1 oxidation is absent in ∆tpx1 cells and therefore 
Tpx1 acts as a signal transducer to activate PAP1-dependent gene expression at low hydrogen 
peroxide levels in Schizosaccharomyces pombe (Brown et al., 2013). If extracellular 
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hydrogen peroxide reaches high levels (≥1 mM), peroxiredoxins are hyperoxidised and PAP1 
is reduced to an inactive form by thioredoxin-like protein 1 (Trxl1) and PAP1-dependent 
gene expression is stopped. 
Thus, it is clear that peroxiredoxins are more than simply hydrogen peroxide 
scavengers and the role of peroxiredoxins in signalling and hydrogen peroxide detoxification 
could be better understood through the use of systems biology tools such as computational 
modelling. The usefulness of these tools and the current limitation of their application in 
understanding peroxiredoxin networks will be discussed further below.  
1.5 Systems biology studies for understanding the peroxiredoxin system 
Determining the activity of biological systems is difficult, as their interactions and 
behaviour are typically too complex to be able to predict from the properties of the 
constituent components (Chiang et al., 2014). In silico analyses of these complex systems are 
therefore necessary and have become feasible using systems biology tools. In particular, 
kinetic modelling with systems biology tools can describe each species and reaction in a 
system using ordinary differential equations (ODE) (Ideker et al., 2001). These models can 
include information about which proteins in a system interact, their rates of interaction or if 
necessary their activation or degradation. Thus, a vast amount of data can be incorporated 
into a single computational model, which can provide insight into the behaviour of the system 
as a whole. A number of important system properties can also be predicted using system 
biology tools, such as the effect of perturbing some component on the system behaviour. 
Further, higher order tools such as control analysis, can be used to quantitatively describe the 
contribution of individual reactions to the flux and steady state concentrations of the system 
(Fell, 2005). 
Unfortunately, there are some discrepancies as to how peroxiredoxins have been 
described in computational modelling studies (Table 1.1). These discrepancies involve 
differences in the kinetic models chosen to describe peroxiredoxin activity as well as the rate 
constants used for hydrogen peroxide reduction. These discrepancies will be described in 




Table 1.1 Kinetic modelling in a number of published computational studies have made use 
of different kinetic expressions, structural descriptions and rate constants for peroxiredoxins. 
Reference Kinetic Expression Structure Rate constant for 
hydrogen peroxide 
reduction 
Johnson et al. (2005) Mass action Monomer 105 M-1 s-1 
Adimora et al. (2010) Mass action Monomer 107 M-1 s-1 
Pillay et al. (2011) Mass action Monomer 104 M-1 s-1 
Aon et al. (2012) Mass action Monomer 107 M-1 s-1 
Benfeitas et al. (2014) Mass action Dimer 105-108 M-1 s-1 
Lim et al. (2015) Mass action Monomer 107 M-1 s-1 
Adolfsen and Brynildsen (2015) Ping-Pong Enzyme Monomer 105 M-1 s-1 
 
1.5.1 Distinct kinetic models for peroxiredoxin activity 
The first unresolved discrepancy about peroxiredoxin activity is the choice of kinetic 
model to describe hydrogen peroxide reduction (Figure 1.6). These models represent a typical 
2-Cys peroxiredoxin, as these are the most common isoform of peroxiredoxins in vivo. The 
first model (ping-pong enzyme model, Figure 1.6A), describes the traditional view that 
peroxiredoxins are enzymes with ping-pong kinetics (Baker and Poole, 2003; Adolfsen and 
Brynildsen, 2015). In the second model (redox couple monomer model, Figure 1.6B), 
peroxiredoxins have been treated as redox couples whose activity has been described with 
mass action kinetics (Johnson et al., 2005; Lim et al., 2015). Finally, in the third model 
(redox couple homodimer model, Figure 1.6C), peroxiredoxins are also considered redox 
couples and their activity is described with mass action kinetics. However, in this scheme 





Figure 1.6 Peroxiredoxin activity has been described using ping-pong enzyme kinetics with 
hydrogen peroxide and thioredoxin as substrates (A) and mass action kinetics to model 
peroxiredoxins as redox couples (B). Peroxiredoxins have also been modelled in their 
homodimer form rather than as monomers (C). Each subunit in the homodimer is oxidised by 
hydrogen peroxide sequentially, which is represented by a statistical value of 2 in the 
computational models and TrxSS/ TrxSH refers to oxidised/reduced thioredoxin and 
PrxSS/PrxSH refers to oxidised/reduced peroxiredoxin 
Systems biology studies based on these kinetic models may give different predictions 
about the system and would therefore affect our understanding of peroxiredoxin dependent 
processes. Meaningful analysis of peroxiredoxin activity would therefore benefit from 
determining which model should be used to describe the system. 
1.5.2 Discrepancies with the rate constant for hydrogen peroxide reduction 
A basic condition in most in vitro enzyme kinetic studies is that the substrate 
concentration in a reaction must greatly exceed that of the enzyme concentration for the 
Michaelis-Menten assumptions to be valid (Segel, 2013). Most in vitro kinetic analyses of 
peroxiredoxins have therefore typically been carried out with higher hydrogen peroxide 
concentrations than peroxiredoxin concentrations and kinetic parameters such as kcat and Km 
have been calculated under these conditions (see for example Jara et al., 2007). However, 
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peroxiredoxins do not meet this basic assumption in vivo as the intracellular peroxiredoxin 
concentration observed is far greater than that of hydrogen peroxide (Huang and Sikes, 
2014). The physiological relevance of results from such analyses is therefore questionable as 
the concentrations of the different species in these assays do not reflect the in vivo 
concentrations of these species. The in vitro kinetic behaviour of peroxiredoxins under 
physiological hydrogen peroxide and peroxiredoxin concentrations has not been described in 
the literature. 
Another discrepancy that has been uncovered with previous studies of peroxiredoxin 
systems surrounds the rate of peroxiredoxin activity with hydrogen peroxide (Figure 1.7). In 
some analyses, NADPH oxidation of the coupled peroxiredoxin system has been used to 
determine the hydrogen peroxide reduction rate constant, while other studies have directly 
monitored the degradation of hydrogen peroxide in a competition assay with horse radish 
peroxidase (HRP) (Ogusucu et al., 2007). Results from these studies have been contradictory, 
with NADPH oxidation occurring at an appreciably slower rate than the hydrogen peroxide 
degradation rate directly observed in the competition assay (Munhoz and Netto, 2004; 
Ogusucu et al., 2007). Thus, and somewhat surprisingly, the reaction of peroxiredoxins and 
hydrogen peroxide may be proceeding faster than the system flux. While the competition 
assay is carried out in the absence of the peroxiredoxin recycling system (thioredoxin, 
thioredoxin reductase and NADH), this method is considered to yield a more accurate 
measure of Prx-dependent hydrogen peroxide reduction (Nelson and Parsonage, 2011). 
However, in the absence of the other peroxiredoxin system components, hyperoxidation of 
eukaryotic peroxiredoxins is inefficient (Cao et al., 2014) and mutants of thioredoxin and 
thioredoxin reductase show great sensitivity to hydrogen peroxide (Ragu et al., 2014), 
suggesting that peroxiredoxin activity is limited by its recycling system in vivo. Thus, 
although this competition assay shows the peroxidase potential of peroxiredoxins, monitoring 




Figure 1.7 The peroxiredoxin rate constant for hydrogen peroxide reduction has varied 
depending on the method used to assay peroxiredoxin activity (Munhoz and Netto, 2004; 
Ogusucu et al., 2007; Nelson et al., 2008; Benfeitas et al., 2014). 
1.6 Aims of study 
The first aim of this research was to determine the appropriate description of 
peroxiredoxins for systems biology studies. Computational models based on peroxiredoxin 
kinetics were simulated to determine if there were distinguishable quantitative and qualitative 
differences in their behaviour. The second aim was to use computational modelling and in 
vitro kinetics to determine the most appropriate method for analysing hydrogen peroxide 
reduction by peroxiredoxins in context of its cognate system. For clarity, the three kinetic 
descriptions of the peroxiredoxin system were referred to as the peroxiredoxin “kinetic 
models” (ping-pong enzyme, redox couple monomer and homodimer models), while an ODE 
model of the entire peroxiredoxin system (peroxiredoxin, thioredoxin, thioredoxin reductase 





Computational modelling of the peroxiredoxin system to 
distinguish its kinetic activity in vitro 
2.1 Introduction 
 The basis for the discrepancies in the reported rate constants for peroxiredoxin 
activity has largely come from the methodologies used to characterise them. Peroxiredoxin 
activity has been studied using several in vitro assays since yeast peroxiredoxin TSA1 was 
first tested for its ability to protect glutamine synthetase from inactivation by the 
DTT/Fe3+/O2 oxidation system (Chae et al., 1994b). Steady state system analysis with an 
NADPH-coupled assay yielded a second-order rate constant for hydrogen peroxide reduction 
(kcat/Km) of 104 M-1 s-1 (Munhoz and Netto, 2004). Assays were subsequently developed that 
omitted peroxiredoxin recycling in the steady state assay and directly measured hydrogen 
peroxide reduction using a competition assay with HRP. In these studies, peroxiredoxins 
were shown to rapidly react with peroxide substrates with second-order rate constants ranging 
from 105 to 108 M-1 s-1 (Ogusucu et al., 2007; see for example Nagy et al., 2011). Directly 
monitoring substrate degradation (see for example Trujillo et al., 2006) or peroxiredoxin 
oxidation (see for example Nelson et al., 2008) further refined this approach and fluorescence 
measurements at specific excitation wavelengths determined pseudo-first order rate constants 
(kobs) for hydrogen peroxide reduction of between 106 to 108 M-1 s-1. Peroxiredoxins were 
consequently proposed to be the primary cellular contributors to hydrogen peroxide 
degradation (Winterbourn and Hampton, 2008; Perkins et al., 2015) which was confirmed by 
gene knockout studies in Escherichia coli (Seaver and Imlay, 2001), S. cerevisiae (Trotter et 
al., 2008) and S. pombe (Paulo et al., 2014). 
 Although peroxiredoxins may rapidly react with hydrogen peroxide, their activity like 
other peroxidases, may be limited by recycling with reductants such as thioredoxin (Mishra 
and Imlay, 2012), which may put their rate constants for hydrogen peroxide degradation in 
the range reported for steady state analysis of the system (Munhoz and Netto, 2004). While 
this steady state rate constant is lower than the rate constants determined with the direct 
assays described above, it is still greater than other peroxidases and, as peroxiredoxins are 
also more abundant in cells (Rabilloud et al., 1995), they are still considered to be the 
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primary antioxidants during peroxide stress. Further support for the lower rate constant has 
come from a large scale computational model of the red blood cell peroxiredoxin system 
(Benfeitas et al., 2014). In this model, peroxide reduction was indeed limited by the 
peroxiredoxin reduction suggesting that computational models that use rate constants of 106 -
108 M-1 s-1 without consideration of peroxiredoxin recycling are incorrect (Benfeitas et al., 
2014).  
 As described in Chapter 1, a further discrepancy noted in the literature is that three 
models for peroxiredoxin kinetic activity have been proposed although it could be argued that 
the ping-pong enzyme and redox couple monomer models are similar. The major difference 
between these two kinetic models is that the ping-pong kinetic mechanism explicitly includes 
the formation of the enzyme-substrate complex (*, Scheme 2.1 and 2.2, Cleland, 1963) which 
is implicit in the redox couple monomer model mechanism. 
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To determine if these kinetic models do indeed make distinct predictions about the 
peroxiredoxin system, core computational models with hydrogen peroxide reduction were 
developed and compared. In addition, realistic computational models based on in vitro 
datasets were developed and their behaviour in response to parameter changes were 
compared. Flux control analysis was also performed to compare the predicted functional 
organisation of the peroxiredoxin system and the rate limiting steps in these systems were 
identified.  
2.2 Methods 
2.2.1 Core computational modelling of the peroxiredoxin system 
 Core computational modelling of the peroxiredoxin system was carried out with 
simplified kinetic parameters to determine if there were any differences between the model 
predicted behaviours of the system (Tables 2.1-2.2). To simplify analysis it was assumed that 
all reactions were irreversible given the large differences in the redox potentials of NADPH, 
thioredoxin, peroxiredoxin and hydrogen peroxide (Wood, 1988; Finn et al., 2003; Watson et 
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al., 2003; Cox et al., 2009; Garcia-Santamarina et al., 2014). The Python Simulator for 
Cellular Systems (PySCeS) (Olivier et al., 2005, http://pysces.sourceforge.net) was used for 
modelling analyses and the model and scripting files were written using Scintilla Text Editor 
(SciTE) (http://sourceforge.net/projects/scintilla/files/SciTE) and are available in the 
Appendix (1.1-1.2). 
2.2.2 Realistic computational modelling of the peroxiredoxin system  
 Realistic models of the peroxiredoxin system were developed by modifying the core 
model scripts in SciTE with realistic reaction parameters and species concentrations obtained 
from BRENDA parameter database (http://www.brenda-enzymes.info) or from the literature 
(Tables 2.3-2.6, Results). Data fitting scripts (Appendix 2.1-2.2) were produced in the Python 
Notebook to fit all of the models to specific datasets using the Levenberg–Marquardt 
algorithm for non-linear least squares regression analysis which was available from SciPy 
(http://www.scipy.org). The data points in the in vitro datasets were obtained using 
PlotDigitizer 2.6.5 (http://sourceforge.net/projects/plotdigitizer/files/plotdigitizer/2.6.5/).  
2.2.3 Flux control analysis of the peroxiredoxin system. 
 Flux control analysis of each kinetic model was completed in the Python Notebook 
(Appendix 2.14 and 2.2.4) using PySCeS. 
2.3 Results 
2.3.1 Core computational modelling revealed quantitative and qualitative differences 
between the peroxiredoxin kinetic models in response to changes in the system 
 The steady-state properties of the three proposed peroxiredoxin kinetic models 
(Figures 1.4 and 1.6) with core parameters (Tables 2.1-2.2) were compared by simulating the 
models at steady state using both linear (Figure 2.1A-D) and logarithmic plots (Figure 2.1E-
F, Hofmeyr and Cornish-Bowden, 2000). The fluxes at different thioredoxin reductase and 
thioredoxin concentrations were analysed as peroxiredoxin reduction may be rate-limiting in 
the system. In all the models the flux increased similarly over all thioredoxin concentrations 
tested (Figure 2.1A and E), but different limiting rates were observed with increasing 
thioredoxin reductase concentrations (Figure 2.1B and F); system saturation occurred at a 
slightly lower thioredoxin reductase concentration in the ping-pong enzyme and redox couple 
monomer models as peroxiredoxin oxidation became the rate-limiting step in these systems.  
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Table 2.1 Reactions and reaction parameters for core computational modelling of the 
peroxiredoxin system. 
Reaction Parameter Value 
All Models  
R1: NADPH + TrxSS → NADP+ + TrxSH kcat 1  1 s-1 
 Knadph 1 µM 
 Ktrxss 1 µM 
Ping-Pong Enzyme Model 
R2: TrxSH + H2O2 → TrxSS + H2O kcat 2 1 s-1 
 Ktrxsh 1 µM 
 Kh2o2 1 µM 
Redox Couple Monomer Model 
R2: H2O2 + PrxSH → H2O + PrxSS k2 1 µM s-1 
R3: PrxSS + TrxSH → PrxSH + TrxSS k3 1 µM s-1 
Redox Couple Homodimer Model 
R2: PrxSHPrxSH + H2O2 → PrxSSPrxSH + H2O k2 1 µM s-1 
R3: PrxSSPrxSH + H2O2 → PrxSSPrxSS + H2O k2 1 µM s-1 
R4: PrxSSPrxSS + TrxSH → PrxSSPrxSH + TrxSS k3 1 µM s-1 
R5: PrxSSPrxSH + TrxSH → PrxSHPrxSH + TrxSS k3 1 µM s-1 





Table 2.2 Species concentrations of all system components for core computational modelling 
of the peroxiredoxin system. 
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Figure 2.1 Flux-response analysis of the ping-pong enzyme, redox couple monomer and 
redox couple homodimer models for peroxiredoxin activity. Flux analysis was carried out to 
observe the sensitivity of each model to parameter changes in the system in linear (A-D) and 
double log space (E-H). 
 Compared to the perturbations in the thioredoxin system (Figure 2.1A-B), substrate 
saturation of the models was observed at relatively low hydrogen peroxide concentrations 
with the maximal flux slightly greater in the redox couple homodimer model (Figure 2.1C 
and G). The effect of changing peroxiredoxin concentrations in the system revealed that the 
maximal flux in the redox couple homodimer model was appreciably different to the ping-
pong enzyme and redox couple monomer models (Figure 2.1D). Interestingly, flux analysis 
in double log space (Figure 2.1H) revealed a sigmoidal response to increasing peroxiredoxin 
concentrations in the redox couple homodimer model. In summary, the models showed 
similar kinetic profiles to some parameters changes but quantitative differences with varying 
thioredoxin reductase, hydrogen peroxide and peroxiredoxin concentrations were apparent in 
these core models.  
 In addition to the flux through the system, the reduced and oxidised thioredoxin 
concentrations also represent an important output of the peroxiredoxin system. At steady 
state, many thioredoxin-dependent reactions are affected by the reduced thioredoxin 
concentration (Pillay et al., 2011). Consequently, the reduced and oxidised thioredoxin 
concentrations were also monitored in these models. With changes in peroxiredoxin and 
thioredoxin reductase concentrations, a switch in the proportion of the reduced to oxidised 
thioredoxin was observed at slightly different concentrations between the models (Figure 
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2.2). As peroxiredoxin concentrations increased, the demand for reduced thioredoxin to 
recycle peroxiredoxin increased, resulting in greater oxidised thioredoxin concentrations at 
steady state (Figure 2.2A). The flux in the redox couple homodimer model was much greater 
than the other models (Figure 2.1D and H) and therefore the thioredoxin oxidation rate was 
also greater and the crossover to a larger fraction of oxidised thioredoxin occurred at a much 
lower peroxiredoxin concentration relative to the other models. This crossover region was 
important as it can be experimentally detected in redox alkylation studies (Padayachee and 
Pillay, 2015) and may therefore be used to distinguish between the proposed peroxiredoxin 
kinetic models. As the thioredoxin reductase concentrations increased, the thioredoxin 
reduction rate increased and consequently the reduced thioredoxin fraction increased relative 
to the oxidised thioredoxin fraction (Figure 2.2B). The flux response to thioredoxin reductase 
was again greater in the redox couple homodimer model (Figure 2.1B and F) and therefore 
the thioredoxin reduction rate was greater than the other models causing the crossover to 
reduced thioredoxin to occur at a lower thioredoxin reductase concentration (Figure 2.2B). 
 
Figure 2.2 Core computational models for peroxiredoxin activity show quantitative 
differences in the steady state reduced and oxidised thioredoxin concentrations in response to 
increasing peroxiredoxin (A) and thioredoxin reductase (B) concentrations. 
 With increasing hydrogen peroxide concentrations, a crossover in the proportion of 
reduced to oxidised thioredoxin concentration occurred in the ping-pong enzyme and redox 
couple monomer models albeit at slightly different hydrogen peroxide concentrations (Figure 
2.3). Notably, in the redox couple homodimer model, the oxidised thioredoxin concentration 
was greater than the reduced thioredoxin concentration over all concentrations of hydrogen 
peroxide supplied to the system. In this model, substrate saturation occurred at a lower 
hydrogen peroxide concentration than the ping-pong enzyme and redox couple models 
(Figure 2.3) causing complete thioredoxin oxidation at a low hydrogen peroxide 
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concentration (Figure 2.3). These differences suggested the dynamics of these kinetic models 
were different and offered a way to distinguish them. 
 
Figure 2.3 Core computational models for peroxiredoxin activity show differences in the 
redox state of thioredoxin in response to increasing hydrogen peroxide concentrations.  
 Differences in the thioredoxin redox state with changes to the NADPH concentration 
were also noted (Figure 2.4) with the reduced thioredoxin form dominating in the ping-pong 
enzyme model at high concentrations of NADPH as there was more NADPH available to 
reduce thioredoxin (Figure 2.4A). The reduced and oxidised thioredoxin concentrations were 
almost equal in the redox couple monomer model (Figure 2.4B). However in the redox 
couple homodimer model, the oxidised form was present in a greater concentration than the 
reduced form over all NADPH concentrations (Figure 2.4C). It is not clear why these results 
differed from the thioredoxin reductase parameter perturbations as both parameters should 
have increased the reducing equivalents available for peroxiredoxin reduction.  
In conclusion, core modelling results suggested that the kinetic models proposed for 
peroxiredoxin activity are expected to show similar kinetic properties in some cases but in 
other cases, notable differences in their behaviour were observed and resulted in models with 
distinct properties especially with regard to the thioredoxin redox state. As thioredoxin is a 
control hub protein for many redox regulated processes (Tanaka et al., 2000; Nishiyama et 
al., 2001), this result suggests that computational models that have been built with these 
different kinetic models (Table 1.1) are expected to have different behaviours even if the 
same set of input parameters were used to develop them. To confirm these core modelling 




Figure 2.4 Changes in the NADPH concentration results in distinct changes to the 
thioredoxin redox couple in the ping-pong enzyme (A), redox couple monomer (B) and redox 
couple homodimer (C) peroxiredoxin models. 
2.3.2 Kinetic modelling of an in vitro human peroxiredoxin dataset revealed deficiencies 
in our understanding of peroxiredoxin kinetics 
 The human erythrocyte peroxiredoxin system is among the most well studied 
peroxiredoxin systems because of its role in protecting red blood cells (RBC) against ROS 
whose production is catalysed by iron (O'neill and Reddy, 2011; Cho et al., 2014; Bayer et 
al., 2015). A steady-state substrate saturation dataset for human erythrocyte peroxiredoxin 2 
activity was obtained by measuring the NADPH oxidation rate with increasing thioredoxin 
concentrations (Figure 2.5, Manta et al., 2009). The species concentrations were carefully 
selected to ensure that hydrogen peroxide reduction was the purported rate-limiting step in this 
experiment and a rate constant for hydrogen peroxide reduction of 1.0 × 108 M-1 s-1 was 
determined independently using a competition assay with HRP (Manta et al., 2009). Kinetic 
parameters were taken from data in this paper, the BRENDA database and from the literature to 
develop computational models of the system based on the ping-pong enzyme, redox couple 
monomer and homodimer models (Tables 2.3-2.4). The resulting models therefore reflected our 




Table 2.3 Realistic parameters for human peroxiredoxin 2 activity for modelling of an in 
vitro dataset (Manta et al., 2009).  
Reaction Parameter Value Reference 
All Models 
R1: NADPH + TrxSS → NADP+ + TrxSH 
kcat 1 25.78 s-1 (Turanov et al., 
2006) 
 Knadph 6 µM (Urig et al., 2006) 
 
Ktrxss 1.83 µM (Turanov et al., 
2006) 
Ping-Pong Enzyme Model 
R2: TrxSH + H2O2 → TrxSS + H2O kcat 2 13.2 s-1 a 
 Ktrxsh 3.24 µM (Manta et al., 2009) 
 Kh2o2 0.7 µM (Manta et al., 2009) 
Redox Couple Monomer Model 
R2: H2O2 + PrxSH → H2O + PrxSS k2 100 μM-1 s-1 (Manta et al., 2009) 
R3: PrxSS + TrxSH → PrxSH + TrxSS k3 0.074 μM-1 s-1 (Manta et al., 2009) 
Redox Couple Homodimer Model 
R2: PrxSHPrxSH + H2O2 → PrxSSPrxSH + 
H2O 
k2 100 μM-1 s-1 (Manta et al., 2009) 
R3: PrxSSPrxSH + H2O2 → PrxSSPrxSS + 
H2O 
k2 100 μM-1 s-1 (Manta et al., 2009) 
R4: PrxSSPrxSS + TrxSH → PrxSSPrxSH + 
TrxSS 
k3 0.074 μM-1 s-1 (Manta et al., 2009) 
R5: PrxSSPrxSH + TrxSH →PrxSHPrxSH + 
TrxSS 
k3 0.074 μM-1 s-1 (Manta et al., 2009) 
a estimated by data fitting De Franceschi et al. (2011) 
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Table 2.4 Species concentrations of the various system components used in each model for 
realistic modelling of human peroxiredoxin 2 activity obtained from Manta et al. (2009). 









H2O2 30  
Ping-Pong Enzyme Prx 0.5 








*Note that the total concentration (reduced and oxidised) of all moiety conserved species is 




Figure 2.5 The effect of increasing human thioredoxin (hTrx) concentration on human 
peroxiredoxin 2 system activity was monitored in an NADPH-coupled assay. The assay 
consisted of 200 µM NADPH, 1 µM thioredoxin reductase, 0.5 µM peroxiredoxin and 30 µM 
H2O2 in 50 mM Tris–HCl buffer at pH 7.4 (Manta et al., 2009). 
 
Figure 2.6 Kinetic models of a mammalian peroxiredoxin system failed to reproduce an in 
vitro dataset (Manta et al., 2009) with increasing thioredoxin concentrations.  
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 As a first step, the realistic peroxiredoxin computational models were simulated with 
increasing thioredoxin concentrations but all the models failed to reproduce this in vitro 
dataset and the responses also differed between the models (Figure 2.6). This discrepancy 
revealed a limitation in our current understanding of peroxiredoxin kinetics and showed that 
the kinetic models proposed for peroxiredoxin activity are indeed quantitatively distinct from 
each other (Figure 2.6). The models were then fit to this in vitro dataset using non-linear 
regression to estimate the parameters for hydrogen peroxide reduction (Table 2.5).  
 All the models were able to fit the in vitro dataset (r2 ≥ 0.98, Table 2.5), suggesting 
that kinetic experiments that utilise this set of experimental conditions only will not be able to 
distinguish between these models. The fitted rate constants for hydrogen peroxide reduction 
were 1.87 × 104 M-1 s-1 (kcat/Km) in the ping-pong enzyme model, 6.67 × 103 M-1 s-1 in the 
redox couple monomer model and 3.33 × 103 M-1 s-1 in the redox couple homodimer model 
(Table 2.5), which conflicted with the rate constant of 108 M-1 s-1 determined with the HRP 
competition assay (Manta et al., 2009) but was closer to rate constants (~104 M-1 s-1) obtained 
in assays that measure the steady state system rate (see for example Munhoz and Netto, 
2004). These results suggests that the rate of hydrogen peroxide reduction by the 
peroxiredoxin system is not solely determined by the rate constant for hydrogen peroxide 
reduction and modelling results based on this assumption must be viewed with caution (see 
for example Winterbourn and Hampton, 2008). We then asked whether the fitted models 
were different to each other by simulating and comparing the responses between the models 
to parameter changes in the system (Figure 2.7).  
With increasing thioredoxin reductase (Figure 2.7A and D) and peroxiredoxin 
concentrations (Figure 2.7B and E), the ping-pong enzyme and redox couple monomer 
models showed a similar flux response that was distinct from the redox couple homodimer 
model. Quantitative differences were also observed in the flux response to increasing 
hydrogen peroxide concentrations in all three models with the redox couple homodimer 
model saturating at a lower hydrogen peroxide concentration than the other models (Figure 




Table 2.5 Parameters determined by fitting of the peroxiredoxin activity models to the human 
erythrocyte peroxiredoxin 2 in vitro dataset using non-linear regression analysis.  
Parameter Value Fitted Curve 
All Models 
In vitro dataset (•) 
Ping-pong enzyme model (−) 
Redox couple monomer model (−) 
Redox couple homodimer model (−) 
kcat 1 (TR) 0.179 s-1 
Ping-Pong Enzyme Model 
 
kcat 2 (Prx) 0.311 s-1 
Km (H2O2) 16.59 µM 
r2 0.99 
Redox Couple Monomer Model 
 
k2 6.67 × 103 M-1 s-1 
k3 9.59 × 104 M-1 s-1 
r2 0.98 
Redox Couple Homodimer 
Model 
 
k2 3.33 × 103 M-1 s-1 
k3 4.80 × 104 M-1 s-1 
r2 0.99 
 




Figure 2.7 The responses of the fitted ping-pong enzyme, redox couple monomer and redox 
couple homodimer models for human erythrocyte peroxiredoxin 2 activity (Manta et al., 
2009) to parameter changes were compared in linear (A-C) and log scale (D-F). The 
responses of the ping-pong enzyme (black) and redox couple monomer (red) models overlap 
in A, B, D and E. 
As with the core modelling (Figure 2.2-2.5), the thioredoxin redox state was then 
monitored to determine if there were also qualitative and quantitative differences in the 
response of the models. Firstly, the reduced thioredoxin concentration remained greater than 
the oxidised thioredoxin concentration over all hydrogen peroxide concentrations tested in 
the ping-pong enzyme and redox couple monomer model (Figure 2.8). However, in the redox 
coupler homodimer model, thioredoxin distributed into the oxidised form, consistent with the 
saturation of this model at a low hydrogen peroxide concentration (Figure 2.7C and F). The 
fitted redox couple homodimer model also showed a distinct quantitative response to 
increasing thioredoxin reductase and peroxiredoxin concentrations, while the ping-pong 
enzyme and redox couple monomer models had near identical responses to changes in these 
parameters (Figure 2.9). In summary, all three proposed kinetic models for peroxiredoxin 
activity can be fitted to the in vitro dataset described by Manta et al. (2009) and the 
parameters obtained by fitting the whole system of reactions did not agree with the 
parameters obtained when peroxiredoxin reduction of hydrogen peroxide was studied in 
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isolation of its cognate system using a competition assay. Finally, while the fitted ping-pong 
enzyme and redox couple monomer models showed similar responses in terms of flux and 
redox state of thioredoxin over most of the parameters tested, the redox couple homodimer 
model showed distinct responses to these parameters perturbations. 
 
Figure 2.8 The fitted models for peroxiredoxin activity showed differences in the steady state 
reduced and oxidised thioredoxin concentrations in response to increasing hydrogen peroxide 
concentrations. 
 
Figure 2.9 The redox couple homodimer fitted model for peroxiredoxin activity predicted 
different steady state reduced and oxidised thioredoxin concentrations to the ping-pong 
enzyme and redox couple monomer fitted models with increasing peroxiredoxin (A) and 
thioredoxin reductase (B) concentrations.   
2.3.3 Flux control patterns of the fitted human peroxiredoxin 2 kinetic models 
 Operationally, flux control coefficients represent the percentage change, positive or 
negative, in the system flux caused by a one percent change in a single reaction. (Fell, 2005). 
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The flux control co-efficient can be precisely described using equation 2.3; where 𝐽 
represents the system flux and 𝑣𝒾 represents the rate of reaction, 𝒾 (Fell, 1997).  










                                        (2.3) 
 Using PySCeS, flux control coefficients were determined for the fitted peroxiredoxin 
activity models to understand the flux control in each of the fitted models (Table 2.5). No 
single reaction (flux control coefficient ~ 1) held complete flux control in both the fitted 
ping-pong enzyme and redox couple monomer models, suggesting that hydrogen peroxide 
reduction was not the sole rate-limiting step despite the experimental conditions chosen for 
this purpose (Manta et al., 2009). Interestingly, in both models, the flux control coefficient 
for thioredoxin reduction (Reaction 1, Table 2.6) were a similar value (0.232) and the 
peroxiredoxin redox cycle held the remaining flux control (0.768), emphasizing the similarity 
of these two models. In the fitted redox couple homodimer model, flux control was mostly 
distributed across the thioredoxin reduction and hydrogen peroxide reduction reactions and 
again no single reaction could be described as rate-limiting in this system. The redox couple 
homodimer model therefore had a complex flux control pattern suggesting that assigning a 
rate-limiting step in the system would be difficult under these experimental conditions. These 
flux control patterns suggest that fitting of an entire computational model to in vitro kinetic 
datasets may be the best method to determine kinetic parameters for this system (see for 
example Pillay et al., 2009; Mashamaite et al., 2015; Padayachee and Pillay, 2015).  
 
Table 2.6 Comparison of flux control coefficients for each reaction in the peroxiredoxin 
kinetic activity models fitted to the human peroxiredoxin 2 dataset * 
Reactions Flux Control  Coefficients 
Ping-Pong Enzyme Model 
1 𝐶𝑅1
𝐽𝑅1 = 0.232 
NADPH + TrxSS → NADP+ + TrxSH 𝐶𝑅2
𝐽𝑅1 = 0.768 
2 𝐶𝑅1
𝐽𝑅2 = 0.232 
TrxSH + H2O2 → TrxSS + H2O 𝐶𝑅2




*Table has been truncated to exclude reactions with low flux control, for the full table of 
reactions refer to the appendix (Table S1, Appendix 2.14). The reaction with the highest flux 
control is shown in column three for clarity.  
Redox Couple Monomer Model 
1 𝐶𝑅1
𝐽𝑅1 = 0.232 
NADPH + TrxSS → NADP+ + TrxSH 𝐶𝑅2
𝐽𝑅1 = 0.313 
 𝐶𝑅3
𝐽𝑅1 = 0.455 
2 𝐶𝑅1
𝐽𝑅2= 0.232 










Redox Couple Homodimer Model* 
1 𝐶𝑅1
𝐽𝑅1= 0.771 








PrxSSPrxSH + H2O2 → PrxSSPrxSS + H2O 𝐶𝑅4
𝐽𝑅3= 0.242 
4 𝐶𝑅1
𝐽𝑅4 = 0.733 
PrxSSPrxSS + TrxSH → PrxSSPrxSH + TrxSS 𝐶𝑅4
𝐽𝑅4 = 0.242 
5 𝐶𝑅3
𝐽𝑅5= -0.977 





2.3.4 Kinetic modelling of an in vitro bacterial peroxiredoxin dataset confirms a 
deficiency in our understanding of peroxiredoxin kinetics 
 The regulation and activity of mammalian peroxiredoxins is considered to be more 
complex than bacterial peroxiredoxins as they are considerably more susceptible to 
hyperoxidation by hydrogen peroxide (Section 1.3.2). The peroxiredoxin kinetic models were 
also fitted to a bacterial substrate saturation dataset to see if the differences observed in the 
mammalian dataset were present in a ‘simpler’ bacterial system.  
 Caulobacter crescentus peroxiredoxin activity was determined by measuring NADPH 
oxidation at 340 nm with increasing hydrogen peroxide concentrations (Figure 2.10, Cho et 
al., 2012). For realistic system modelling, kinetic parameters were obtained from the 
BRENDA parameter database for the E. coli thioredoxin and thioredoxin reductase which 
were used in this assay. Simulation of the peroxiredoxin activity models with these 
parameters (Table 2.7) and the species concentrations used in this assay (Table 2.8, Cho et 
al., 2012) failed to reproduce the in vitro dataset and the responses also differed between the 
models (Figure 2.11) as was seen with the human peroxiredoxin dataset (Figure 2.6).  
Table 2.7 Realistic parameters used for modelling of a C. crescentus peroxiredoxin in vitro 
dataset (Cho et al., 2012).  
Reaction Parameter Value Reference 
All Models 
R1: NADPH + TrxSS → NADP+ + TrxSH kcat 1 22.75 s-1 (Gleason et al., 1990) 
 Knadph 1.2 µM (Williams Jr, 1976) 
 Ktrxss 2.8 µM (Williams Jr, 1976) 
Ping-Pong Enzyme Model 
R2: TrxSH + H2O2 → TrxSS + H2O kcat 2 73 s-1 (Baker and Poole, 2003) 
 Ktrxsh 24 µM (Baker and Poole, 2003) 
 Kh2o2 106 µM (Cho et al., 2012) 
Redox Couple Monomer Model 
R2: H2O2 + PrxSH → H2O + PrxSS k2 0.74 μM-1 s-1 (Cho et al., 2012) 
R3: PrxSS + TrxSH → PrxSH + TrxSS k3 2.98 μM-1 s-1 a 
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Redox Couple Homodimer Model 
R2: PrxSHPrxSH + H2O2 → PrxSSPrxSH + 
H2O 
k2 0.74 μM-1 s-1 (Cho et al., 2012) 
R3: PrxSSPrxSH + H2O2 → PrxSSPrxSS + 
H2O 
k2 0.74 μM-1 s-1 (Cho et al., 2012) 
R4: PrxSSPrxSS + TrxSH → PrxSSPrxSH + 
TrxSS 
k3 2.98 μM-1 s-1 a 
R5: PrxSSPrxSH + TrxSH → PrxSHPrxSH + 
TrxSS 
k3 2.98 μM-1 s-1 a 
a estimated from kcat/Km ratio by Baker and Poole (2003). 
Table 2.8 Species concentrations of the various system components used in each model for 
realistic modelling of the periplasmic peroxiredoxin from C. crescentus obtained from Cho et 
al. (2012). 










Ping-Pong Enzyme Prx 0.5 








*Note that the total concentration (reduced and oxidised) of all moiety conserved species is 




Figure 2.10 The activity of a periplasmic peroxiredoxin from C. crescentus was determined 
in a NADPH-coupled activity assay (Cho et al., 2012). The assay consisted of 100 µM 
NADPH, 8 µM E.coli thioredoxin, 0.5 µM E.coli thioredoxin reductase and 0.5 µM 
peroxiredoxin.  
 
Figure 2.11 Kinetic models of a bacterial peroxiredoxin system failed to reproduce an in vitro 
dataset (Cho et al., 2012) with increasing hydrogen peroxide concentrations. 
 The rate constants used in the computational models for the thioredoxin-dependent 
reduction of peroxiredoxin (k3) were estimated from the E. coli peroxiredoxin system (Baker 
and Poole, 2003). These constants could therefore be different for the C. crescentus 
peroxiredoxin, which could account for discrepancies between the models and the in vitro 
dataset (Figure 2.11). However, these rate constants were in a similar range to rate constants 
reported for other peroxiredoxins and the models were then fitted to this dataset to determine 
parameters for the C. crescentus peroxiredoxin system (Table 2.9).  
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Table 2.9 Kinetic parameters determined by data fitting of the models to the in vitro 
C. crescentus periplasmic peroxiredoxin dataset. 
Parameter Value Fitted Curve 
 
In vitro dataset (•) 
Ping-pong enzyme model (−) 
Redox couple monomer (−) 
Redox couple monomer model (−) 
Ping-Pong Enzyme Model 
 
k cat 2 (Prx) 0.592 s-1 
Ktrxsh 0.347 µM 
r2 0.98 
Redox Couple Monomer Model 
 
k2 5.61 × 103 M-1 s-1 
k3 7.47 × 104 M-1 s-1 
r2 0.98 
Redox Couple Homodimer Model 
 
k2 2.80 × 103 M-1 s-1 
k3 3.73 × 104 M-1 s-1 
r2 0.98 
  
 As with the human peroxiredoxin 2 fitted models (Table 2.5), the rate constants for 
hydrogen peroxide reduction differed from the range of rate constants (106-108 M-1 s-1) 
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usually determined by competition assay for other peroxiredoxins (Table 2.9). The fitted rate 
constant for hydrogen peroxide reduction was 5.58 × 103 M-1 s-1 in the ping-pong enzyme 
model, 5.61 × 103 M-1 s-1 in the redox couple monomer model and 2.80 × 103 M-1 s-1 in the 
redox couple homodimer model (r2= 0.98, Table 2.9). Using these fitted parameters, the 
peroxiredoxin kinetic models were then simulated to determine if there were differences in 
their response to parameter changes. Flux analysis of the models showed that when compared 
to the redox couple monomer and homodimer models, the ping-pong enzyme model had a 
distinct response to increasing thioredoxin reductase (Figure 2.12A and D), thioredoxin 
(Figure 2.12B and E), and peroxiredoxin concentrations (Figure 2.12C and F). The greatest 
difference was observed with increasing thioredoxin concentrations, where the ping-pong 
enzyme model showed substrate saturation at a lower thioredoxin concentrations and the 
maximal flux obtained was also much lower than the other models. The redox couple 
monomer and homodimer models gave near identical response to all parameters changes 
tested in the system (Figure 2.12A-F). 
 
Figure 2.12 The ping-pong enzyme, redox couple monomer and redox couple homodimer 
models for peroxiredoxin activity were fitted to an in vitro C. crescentus peroxiredoxin 
dataset. Changes to the system were monitored in linear and double log space with 150 µM of 
hydrogen peroxide chosen as this concentration is non-saturating in the system (Table 2.9). 




The thioredoxin redox state showed similar response in all the models to most 
parameter changes made to the system (data not shown). However with increasing 
peroxiredoxin concentrations, differences between the ping-pong enzyme model and the 
redox couple monomer and homodimer models were revealed (Figure 2.13). In summary and 
in contrast to the human erythrocyte peroxiredoxin 2 models (Section 2.3.2), the fitted C. 
crescentus redox couple monomer and homodimer models showed similar responses to 
parameter changes that were distinct to some responses of the ping-pong model. These results 
emphasised the complex kinetic relationships between these models and flux control analysis 
was then performed to determine the flux control pattern in these models (Table 2.10) 
 
Figure 2.13 The fitted models for peroxiredoxin activity show differences in the steady state 
reduced and oxidised thioredoxin concentrations in response to increasing peroxiredoxin 
concentrations and a non-saturating hydrogen peroxide concentration of 150 µM. 
2.3.5 Flux control patterns of the fitted periplasmic peroxiredoxin kinetic models 
 Flux control in the fitted ping-pong enzyme model was determined to be primarily in 
the hydrogen peroxide reduction reaction and split between the peroxiredoxin redox cycle 
reactions in redox couple monomer model (Table 2.10). In the fitted redox couple homodimer 
model, a complex flux control pattern was observed with flux control split among several 






Table 2.10 Comparison of flux control coefficients for each reaction in the peroxiredoxin 




Ping-Pong Enzyme Model 
1 
𝐶𝑅2
𝐽𝑅1 = 0.9999 
NADPH + TrxSS → NADP+ + TrxSH 
2 
𝐶𝑅2
𝐽𝑅2 = 0.9999 
TrxSH + H2O2 → TrxSS + H2O 
Redox Couple Monomer Model 
`1 𝐶𝑅1
𝐽𝑅1 = 0.00329 
NADPH + TrxSS → NADP+ + TrxSH 𝐶𝑅2




𝐽𝑅2 = 0.00329 
H2O2 + PrxSH → H2O + PrxSS 𝐶𝑅2




𝐽𝑅3 = 0.00329 
PrxSS + TrxSH → PrxSH + TrxSS 𝐶𝑅2
𝐽𝑅3 = 0.413 
 𝐶𝑅3
𝐽𝑅3= 0.584 
Redox Couple Homodimer Model* 
1 C𝑅3
𝐽𝑅1 = 0.242 





JR2 = -0.345 
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PrxSSPrxSH + H2O2 → PrxSSPrxSS + H2O 𝐶𝑅4
𝐽𝑅3
 = 0.343 
4 𝐶𝑅3
𝐽𝑅4 = 0.656 
PrxSSPrxSS + TrxSH → PrxSSPrxSH + TrxSS 𝐶𝑅4
𝐽𝑅4 = 0.343 
5 𝐶𝑅3
𝐽𝑅5= -0.345 
PrxSSPrxSH + TrxSH → PrxSHPrxSH + TrxSS 𝐶𝑅4
𝐽𝑅5 = 0.341 
 𝐶𝑅5
𝐽𝑅5= 0.827 
*Table has been truncated to exclude the reactions with low flux control, for full table of 
reactions refer to appendix (Table S2, 2.12). The reaction with the highest flux control is 
shown in column three for clarity.  
2.4 Discussion  
 Computational modelling of the peroxiredoxin system aimed to analyse the three 
kinetic descriptions of the system in the literature. Peroxiredoxins have been described with 
both ping-pong and mass action kinetics and the functional unit of their activity has been 
modelled as both a monomer and a homodimer (Figure 1.6). To determine if these 
descriptions were equivalent, peroxiredoxin kinetic models were analysed with core 
parameters which revealed quantitative differences in their responses to increasing 
thioredoxin reductase, hydrogen peroxide and peroxiredoxin concentrations (Figure 2.1). 
Although these kinetic descriptions have been used interchangeably in published literature on 
the system, these results revealed that the computational models based on these peroxiredoxin 
kinetic models are expected to have distinct behaviours and some of the published 
computational models (Table 1.1) are likely to be inaccurate.  
 Simulation of the peroxiredoxin activity models with realistic parameters for human 
peroxiredoxin 2 failed to reproduce an in vitro dataset for this peroxiredoxin (Figure 2.6), 
showing a disconnect between the proposed models for peroxiredoxin activity and the kinetic 
parameters that have been generated for their activity (Manta et al., 2009). The models were 
then fitted to the in vitro dataset to determine the parameters necessary to reproduce the 
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dataset and all the models showed excellent fits, highlighting the complexity of kinetic 
analysis of this system (Table 2.5). Parameter changes made to the fitted models showed 
similar responses in the fitted ping-pong enzyme and redox couple monomer models, while 
the redox couple homodimer model had distinct responses (Figure 2.7 and 2.10). The models 
were also fitted to an in vitro dataset for C. crescentus peroxiredoxin after again failing to 
reproduce the dataset (Figure 2.11). Simulation of the fitted models revealed a similar 
response between the redox couple monomer and homodimer models which was different to 
the response of the ping-pong enzyme model (Figure 2.12 and 2.14) and confirmed that the 
peroxiredoxin kinetic models cannot be used interchangeably. Data fitting of the models 
generated parameters that set the rate constants for hydrogen peroxide reduction in the range 
of 103-104 M-1 s-1 (Table 2.5 and 2.9) which contrasts with rate constants (kobs) of 106-108 M-1 
s-1 that have been reported for peroxiredoxins in absence of their cognate system (see for 
example Nelson et al., 2008; Manta et al., 2009). Recently, a large scale realistic model of 
hydrogen peroxide reduction in erythrocytes (Benfeitas et al., 2014) also reported that the 
rate constant for hydrogen peroxide reduction by peroxiredoxins was in the range of 105 M-1 
s-1. In summary, studying the peroxiredoxin system as a whole and system-wide data fitting 
may be a more accurate method for parameter estimation in vitro.  
Using core modelling, the thioredoxin redox state was monitored with increasing 
thioredoxin reductase, peroxiredoxin, hydrogen peroxide and NADPH concentrations (Figure 
2.2 – 2.5). Qualitative and quantitative differences between the models were observed and 
further support that the proposed peroxiredoxin kinetic models were not interchangeable. 
Analysis of the models with realistic parameters was then carried out which also revealed 
thioredoxin redox state differences with the fitted human peroxiredoxin 2 (Figure 2.8-2.10) 
and C. crescentus models (Figure 2.13). These redox states, which have largely been ignored 
in previous in vitro studies, could be useful outputs for analysing peroxiredoxin activity and 
distinguishing the peroxiredoxin kinetic models.  
Flux control analysis of the peroxiredoxin kinetic models with parameters from both 
the fitted models for human peroxiredoxin 2 (Table 2.6) and C. crescentus peroxiredoxin 
(Table 2.10) revealed that in some kinetic models complete flux control was not in any single 
step. Further, the redox couple monomer and homodimer kinetic models had very complex 
flux control patterns, suggesting that assigning a rate limiting step for this system in vitro is 
not trivial. Collectively, these results argue that it is critical that the correct kinetic model be 
used for peroxiredoxin activity and that whole system fitting may be the most appropriate 
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method for determining the rate constants for hydrogen peroxide reduction. The difference in 
flux control pattern between the models and the quantitative and qualitative differences 
observed between the peroxiredoxin activity models could potentially be used to distinguish 
the models in vitro and determine which model should be used in system biology studies of 






The cloning of yeast peroxiredoxin TSA1 and the purification of 
the peroxiredoxin system proteins. 
3.1 Introduction 
  The S. cerevisiae cytosolic TSA1 peroxiredoxin system was chosen for this project to 
resolve the conflicting descriptions of peroxiredoxin activity. The system consisted of a 
peroxiredoxin, thioredoxin, thioredoxin reductase and NADPH and the steady state system 
rate for hydrogen peroxide degradation could be determined by measuring NADPH 
oxidation at 340 nm (Munhoz and Netto, 2004; Nelson and Parsonage, 2011). Expression 
plasmids for S. cerevisiae thioredoxin (TRX1) and thioredoxin reductase (TRR1) were 
already present in the laboratory for expression and purification of these proteins. The 
cloning of TSA1 and the purification of the TSA1, TRX1 and TRR1 proteins will be 
described below. 
3.2 Materials and Methods 
3.2.1 Materials 
 Polymerases and all other PCR reagents, including PCR primers for the yeast 
peroxiredoxin TSA1, were obtained from Inqaba Biotech (Johannesburg, South Africa). The 
Thermo Scientific (Massachusetts, United States) InsTAclone PCR, Rapid Ligation and 
GeneJET Gel Purification Kits were also purchased from Inqaba Biotech (Johannesburg, 
South Africa). The NEB restriction enzymes (NEB, Massachusetts, United States), NdeI and 
HindIII, were obtained from The Scientific Group (Midrand, South Africa). Dithiothreitol 
(DTT), Coomassie G-250 and R-250 powder, TEMED and ammonium persulfate were 
obtained from Sigma (Capital Labs, Johannesburg, South Africa). Agarose for gel 
electrophoresis and the Qiagen (Hilden, Germany) Ni-NTA agarose resin for protein 
purification were obtained from Whitehead Scientific (Pty) Ltd (Cape Town, South Africa). 
Acrylamide: Bis (37:5:1) ready to use solution was obtained from Merck (South Africa) and 
the non-denaturing PAGE kit for molecular weights 14 kDa – 272 kDa was obtained from 
Sigma (Kawasaki, Japan and distributed by Capital Labs, Johannesburg, South Africa). All 
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other common chemicals such as Tris-HCl and EDTA were of the highest purity available 
and were obtained from Saarchem/Merck (Johannesburg, South Africa).  
3.2.1. Saccharomyces cerevisiae genomic DNA isolation  
 Genomic DNA was isolated from Saccharomyces cerevisiae BY4743 (MATa/MATα 
his3Δ0/his3Δ0 leu2Δ0/leu2Δ0 MET15/met15Δ0 LYS2/lys2Δ0 ura3Δ0 /ura3Δ0) using Bust n’ 
Grab protocol (Harju et al., 2004). An overnight culture of yeast cells grown in YPD media 
was centrifuged to pellet the cells (20 000 × g, 5 minutes, RT). The pellet was resuspended in 
lysis buffer (200 µl, 2% (v/v) Triton X-100, 1% (w/v) SDS, 10 mM Tris-HCl, 1 mM EDTA, 
and 100 mM NaCl, pH 8.0) and the cells were freeze-thawed twice by incubation at -75°C 
(5 minutes) and then at 95°C (1 minute). Chloroform (200 µl) was added to the cell 
suspension, which was then centrifuged (20 000 × g, 3 minutes, RT). Three distinct layers 
were formed and the upper aqueous phase was transferred into a fresh micro-centrifuge tube 
containing 100% (v/v) ice-cold ethanol (400 µl) to precipitate the DNA. The precipitated 
DNA was pelleted by centrifugation (20 000 × g, 5 minutes, RT), the pellet was washed with 
70% (v/v) ethanol (500 µl) and centrifuged (13 000 × g, 1 minute, RT). The pellet was air-
dried and resuspended in TE buffer (100 µl, 10 mM Tris-HCl and 1 mM EDTA, pH 8.0). The 
genomic DNA was analysed by agarose gel electrophoresis and using a NanoDrop™ 2000 
UV-Vis Spectrophotometer to estimate the concentration and purity.  
3.2.2 TSA1 Primer Design  
 PCR primers for TSA1 were designed using Primer3 (bioinfo.ut.ee/primer3-0.4.0/) 
and their specificity was confirmed using Primer Blast (NCBI) to ensure that E. coli 
peroxiredoxins were not inadvertently amplified by PCR. The TSA1 gene was amplified from 
yeast genomic DNA using the forward primer 5'-agccatATGGTCGCTCAAGTTCAAAAGC-
3' containing an NdeI restriction site and the reverse primer 5'-
acgaagcTTATTTGTTGGCAGCTTCGAAG-3' containing a HindIII restriction site 
(underlined). Extra bases were added to the 5' end of the restriction site to aid with cutting of 
the PCR product by restriction enzymes.  
3.2.3 PCR amplification of TSA1 
 PCR was used to clone the yeast peroxiredoxin gene TSA1 and to confirm the 
presence of the gene in plasmids. The PCR reaction contained DreamTaq buffer (1X, 
containing MgCl2), dNTP mix (200 µM), forward and reverse primer (500 nM each), 
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additional MgCl2 was added to give a final reaction concentration of 2.5 mM, template DNA 
(0.2-1 ng), DreamTaq DNA polymerase (0.5 U/25 µl) and sterile nuclease-free water. The 
PCR reaction conditions were as follows: initial denaturation at 94ºC (3 minutes), 
denaturation at 94ºC (30 seconds), annealing 55ºC (30 seconds), extension at 72ºC (1 minute) 
and a final extension at 72ºC (7 minutes or 20 minutes for TA cloning). The PCR reactions 
were run for 25 cycles and the amplicons were visualized by agarose gel electrophoresis to 
estimate the concentration and purity of the product.  
3.2.4 Ligation 
 For all ligation reactions, a molar insert to vector ratio of 3:1 was used. For ligation of 
TSA1 into pTZ57R/T, the Thermo Scientific InsTAclone PCR kit was used while the Thermo 
Scientific Rapid Ligation Kit was used for ligation of TSA1 into pET28a. Ligations were 
performed at room temperature (1 hour) then transferred to 4°C (overnight).  
3.2.5 TA cloning of TSA1 into Escherichia coli JM109 
 To make E. coli JM109 cells competent, C-media (2 ml, Thermo Scientific 
InsTAclone PCR cloning kit) was inoculated with E. coli JM109 cells and grown at 37°C 
(overnight). The E. coli JM109 cell culture (150 µl) was added to fresh pre-warmed 
C-medium (1.5 ml) and incubated at 37ºC (20 minutes, 150 rpm). The cells were then 
pelleted by centrifugation in a desktop centrifuge (maximum speed, 1 minute, RT) and then 
treated with T-solution (300 µl, Thermo Scientific InsTAclone PCR cloning kit) to make the 
cells competent. The ligation mix (2.5 µl) was added to the competent cells and incubated on 
ice (30 minutes). The cells were then plated onto LB agar plates containing ampicillin 
(50 µg/ml), X-gal (80 µg/ml) and IPTG (0.1 mM) for blue/white colony selection. Several 
control plates were also prepared including competent cells on LB media to check the 
viability of the cells, a negative control of competent cells on LB media containing ampicillin 
to check that the ampicillin was not denatured during plate preparation, a negative control of 
competent cells transformed with uncut pTZ57R/T vector and a positive control of competent 
cells transformed with pTZ57R/T vectors that have been ligated with a fragment insert to 
ensure that the cells were competent and that the X-gal and IPTG had not been denatured. 
This final control plate was also used to determine the transformation efficiency. The plates 
were left to grow in an incubator overnight at 37°C, white colonies were then randomly 
chosen from the LB media plates containing ampicillin, X-gal and IPTG and inoculated into 
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LB broth containing ampicillin (100 µg/ml) and grown overnight at 37°C. The plasmids were 
isolated by plasmid mini-prep and the presence of the TSA1 gene insert was confirmed by 
PCR and restriction digestion. 
3.2.6 Plasmid Mini-Prep  
 An alkaline lysis plasmid mini-prep (Sambrook and Russell, 2006) was performed to 
isolate plasmids from an overnight culture (10 ml, 150 rpm). The overnight culture was 
centrifuged (7250 x g, 5 minutes, RT) and the cells were resuspended in GTE solution 
(200 µl, 50 mM glucose, 25 mM Tris-HCl, 10 mM EDTA, pH 8.0), RNase A solution (2 µl, 
20 mg/ml stock) was added and the tube was incubated at room temperature for 5 minutes. 
The cell suspension was transferred to a fresh 1.5 ml Eppendorf tube, NaOH/SDS (400 µl, 
0.2 M NaOH, 1% SDS) was added and the tube was gently inverted six times, then incubated 
at room temperature (5 minutes). Potassium acetate (300 µl, 3 M) was added to the tube, 
which was again gently inverted six times, then incubated at room temperature (5 minutes). 
The tube was centrifuged in a desktop centrifuge (maximum speed, 5 minutes, RT) and the 
supernatant (800 µl) was transferred to a fresh 1.5 ml Eppendorf tube. Ice-cold isopropanol 
(600 µl) was added to the tube, which was then incubated at -20ºC (30 minutes) to precipitate 
the DNA. The tube was then centrifuged in a desktop centrifuge (maximum speed, 
5 minutes), the supernatant discarded and 70% ice-cold ethanol (0.5 ml) was used to wash the 
pellet. The tube was then centrifuged in a desktop centrifuge (maximum speed, 1 minute, 
RT), the supernatant removed and the pellet air-dried for 10 minutes. The pellet was 
resuspended in TE buffer (50 µl, 10 mM Tris-HCl and 1 mM EDTA, pH 8.0). 
3.2.7 Restriction digestion of plasmids 
 Plasmid DNA (1 µg) was digested overnight at 37°C with restriction enzymes NdeI 
(2 U) and HindIII (1 U) in NEB Buffer 2. NdeI cuts both pTZ57R/T and pET28a once while 
HindIII cuts pTZ57R/T once and pET28a twice. For all reactions an uncut control and single 
digest with NdeI or HindIII was performed as controls to check DNA quality prior to 
digestion and to ensure that both enzymes were active. 
3.2.8 Transformation of pET28 with TSA1 into Escherichia coli BL21  
Competent E. coli BL21 cells were made by calcium chloride treatment (Dagert and 
Ehrlich, 1979). In this method, an overnight E. coli BL21 culture (2 ml) was transferred to 
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LB broth (50 ml) and grown until the OD600 reading was between 0.3-0.4. The cell culture 
was chilled on ice (10 minutes) and then centrifuged (4500 x g, 10 minutes, 4ºC). The pellet 
was resuspended in ice-cold CaCl2 (40 ml, 0.1 M) and the cells were then pelleted by 
centrifugation (4500 x g, 10 minutes, 4ºC). The pellet was resuspended in ice-cold CaCl2 
(2 ml, 0.1 M, 30 minutes). Competent cells (20 µl) were then incubated with the ligation mix 
(2.5 µl, 30 minutes, 4ºC), heat shocked (42ºC for 90 seconds) and cooled (4ºC for 2 minutes). 
Pre-warmed SOC media (80 µl at 37°C, 2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM 
MgCl2, 10 mM NaCl, 2.5 mM KCl and 20 mM filter sterilized glucose was added after 
autoclaving) was added to the cells, which were then incubated at 37ºC in a shaking water 
bath (1 hour). The transformation mix (50 µl) was spread on LB agar plates containing 
kanamycin (30 µg/ml) and the cells were grown overnight at 37°C. 
Controls were set up to check viability of the cells after the competent cell treatment, 
to determine transformation efficiency and to ensure that the kanamycin antibiotic in the 
plates was still active. Recombinant colonies were randomly selected from the LB agar plates 
and inoculated into LB broth containing kanamycin (10 ml, 30 µg/ml) which were grown 
shaking overnight at 37°C. The plasmids were isolated by plasmid mini-prep (3.2.2.6) and the 
presence of the TSA1 gene insert was confirmed by PCR and restriction digestion.  
3.2.9 Gel Purification 
Gel purification of double digested PCR and plasmid products was performed using 
the GeneJET Gel Purification Kit (Fermentas). The purified product was then run on agarose 
gel electrophoresis to estimate the concentration and to confirm the purity obtained. 
3.2.10 Agarose gel electrophoresis  
Agarose gel electrophoresis was used for visualisation of all DNA products. A 
1.0% (w/v) agarose gel for genomic DNA samples, 1.2% (w/v) gel for plasmid DNA and a 
1.5% (w/v) gel for PCR products. Ethidium bromide (2 µl, 10 mg/ml stock) was added to 
agarose dissolved in 1 X TAE (40 ml, 40 mM Tris-HCl, 20 mM acetic acid, 1 mM EDTA, 
pH 8.0) and the gel was allowed to polymerize (30 minutes) in a casting tray. Gels were run 
at 80 V until the tracking dye had run ¾ of the length of the gel (90-120 minutes) and the 




3.2.11 Plasmid sequencing 
Two isolated plasmid clone samples, pBETSA1a and pBETSA1b, were sequenced in 
both directions (Central Analytical Facility, Stellenbosch University) and an alignment was 
performed using ClustalX on the resulting sequence data with the TSA1 gene sequence 
(NCBI accession number NC_001145.3). 
3.2.12 Protein expression 
 A high cell density culture method (Sivashanmugam et al., 2009) was used for high 
yield protein expression of TSA1 for purification. E. coli BL21 cells transformed with the 
TSA1 expression plasmid were grown at 37ºC (overnight, A600 ~ 5-7, 150 rpm) in 2 × YT 
media (250 ml, 1.6% (w/v) tryptone, 1% (w/v) yeast extract, 0.5% (w/v) NaCl, pH 7.0), then 
centrifuged (1 500 × g, 10 minutes) and resuspended in high cell density media (2 × YT, 
50 mM Na2HPO4, 25 mM KH2PO4, 5 mM MgSO4, 0.2 mM CaCl2, 0.1% (w/v) NH4Cl, 1% 
(v/v) glucose, pH 8.2). The cells were grown at 37ºC until the A600 had increased by one unit 
(1-1.5 hours, 150 rpm), IPTG (0.5 mM) was then added to the cultures and induction of the 
recombinant protein expression proceeded at 30ºC (1-6 hours, 150 rpm). Cells were 
centrifuged at room temperature (12 000 × g, 10 minutes), the supernatant discarded and the 
weight of the cells recorded. Plasmid clones of TRX1 and TRR1 were kindly supplied by Miss 
L. Padayachee (UKZN) and Miss M. Photolo (UKZN) respectively and these recombinant 
proteins were similarly induced. 
3.2.13 Tris-Tricine Gel Electrophoresis 
 Protein samples were visualised on a 15% Tris-Tricine gel (Table 3.1). Tris-Tricine 
gels were made up with acrylamide: bis (37:5:1) ready to use solution, Gel Buffer (3 M Tris-
HCl, 0.3% (m/v) SDS, pH 8.4), distilled water and polymerisation was initiated with TEMED 
and freshly made 10% (w/v) ammonium persulfate. The resolving gel solution was allowed to 
polymerise for 30 minutes in the gel casting tray before the stacking gel was added and 
polymerised for a further 30 minutes. Protein samples were prepared in reducing or non-
reducing treatment buffer (125 mM Tris-HCl, 0.01% (m/v) bromophenol blue, 4% (m/v) 
SDS, 20% (v/v) glycerol, 10% (v/v) β-mercaptoethanol (reducing buffer only), 0.01% (m/v) 




Gels were run at 50 mA using cathode (0.1 M Tris-HCl, 0.1 M Tricine, 0.1% (m/v) 
SDS, pH 8.25) and anode buffer (0.2 M Tris-HCl, pH 8.9) until the dye front had reached the 
bottom of the gel (~120 minutes). Gels were stained with Coomassie blue gel stain 
(0.125% (m/v) Coomassie brilliant blue R-250, 50% (v/v) methanol and 10% (v/v) acetic 
acid) overnight on a shaker, de-stained with de-stain solution I (45% (v/v) methanol, 9% (v/v) 
glacial acetic acid) until the background was clear and finally placed in de-stain solution II 
(5% (v/v) methanol, 7% (v/v) acetic acid) to rehydrate the gel. Gels were photographed under 
white light using a DNR MiniBIS Pro Versadoc. 
Table 3.1 Tris-Tricine stacking and resolving gel mixture for visualising small proteins. 
 4% Stacking Gel 15% Resolving Gel 
 Volume (ml) 
Water 3 3.71 
Acrylamide: Bisacrylamide Solution 0.67 8 
Gel Buffer  1.3 4 
TEMED 0.005 0.008 
10% Ammonium persulfate 0.025 0.282 
Total Volume 5 16 
 
3.2.14 Preparation of Crude Protein Extract  
 Cell pellets were resuspended in a volume of ice-cold extraction buffer (20 mM Tris-
HCl, 1 mM EDTA, 0.5 mM AEBSF protease inhibitor, 5 mM DTT, 10 mM NaCl, pH 7.5) 
equal to ten times the weight of the cells and sonicated using the Virsonic 60 Ultrasonic Cell 
Disrupter (5 W) for 20 seconds sonication followed by 20 seconds on ice. This procedure was 
repeated three times. The cell suspension was then centrifuged (12 000 × g, 30 minutes at 
4°C) and the supernatant stored at -20°C.  
3.2.15 Nickel Affinity Protein Purification 
Protein purification columns (15 ml total volume) were packed with Ni-NTA agarose 
beads (2 ml) suspended in 20% ethanol. The columns were washed with two volumes of 
equilibration buffer (0.5 M NaCl, 0.02 M imidazole, 0.02 M Tris-HCl, 0.001 M β-
mercaptoethanol, pH 8.0) before the addition of crude protein extract (6 ml). Columns were 
then rotated on a Labnet Revolver 360° sample mixer overnight at 4°C. The unbound crude 
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protein extract was eluted from the column and the column was washed with two volumes of 
wash buffer (0.02 M Tris-HCl, 0.5 M NaCl, 30 mM imidazole, pH 8.0). Elution buffer (3 ml, 
0.02 M Tris-HCl, 0.5 M NaCl, 250 mM imidazole, pH 8.0) was added to the columns, which 
were then rotated for 30 minutes at 4°C. Protein factions were then collected and the columns 
were washed with one volume of 0.5 M NaOH and two volumes of distilled water. The Ni-
NTA resin was stored in the column in 20% ethanol and regenerated once the resin had lost 
its blue colour (~ 5 purifications). The purity of the protein was determined by visualising the 
collected fractions on a 15% Tris-Tricine gel along with samples of the crude protein extract, 
the unbound protein and flow-through from each wash step.  
3.3 Results 
3.3.1 Cloning and sequence confirmation of the TSA1 expression plasmid 
 Genomic DNA was isolated from two cultures of S. cerevisiae BY4743 using Bust n’ 
Grab protocol (Figure 3.1A). A restriction map of the TSA1 gene, generated using NEBcutter 
(tools.neb.com/NEBcutter.com) showed that it did not contain the restriction sites for the 
restriction enzymes NdeI and HindIII. Therefore these restriction sites were incorporated into 
the 5' ends of the TSA1 PCR primers for cloning. The use of NdeI restriction enzyme also had 
an advantage in that its recognition site, CATATG, already contained the ATG start codon 
and thus overlapped the first 5' codon in the TSA1 gene coding sequence which allowed the 
design of primers that could target more of the downstream gene sequence, increasing the 
accuracy of primer binding. The yeast peroxiredoxin TSA1 gene was subsequently PCR 
amplified from the genomic DNA and was determined to be the expected size of 601bp 
(Figure 3.1B). No contamination was present in the no template control reaction. 
The PCR product was gel purified, ligated into pTZ57R/T using a molar insert to 
vector ratio of 3:1 and transformed into E. coli JM109 cells using the Thermo Scientific 
InsTAclone PCR cloning kit. The transformed cells were plated onto LB agar plates 
containing ampicillin, X-gal and IPTG for blue/white colony selection. The control plates 
showed that the E. coli JM109 cells had not been previously transformed with pTZ57R/T, 
had not acquired ampicillin antibiotic resistance and also confirmed that the ampicillin, X-gal 
and IPTG and were still active after preparation of the LB agar plates. The transformation 
efficiency was calculated as 3.78 x 104 CFU/µg of plasmid DNA. 
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Using blue/white colony selection, six recombinant clones were selected and their 
plasmids were isolated to confirm that they contained the TSA1 gene insert by PCR (Figure 
3.1C). All six samples had a positive PCR result and no contamination was present in the no 
template control. Three of the confirmed plasmids (pTTSA1a, pTTSA1b, pTTSA1c) were 
again tested for the presence of the TSA1 gene insert by restriction digestion. Double 
digestion of the plasmids with NdeI and HindIII liberated the TSA1 insert from the plasmids 
(Figure 3.2). As a control, the plasmids were also digested with either NdeI or HindIII, to 
ensure that the enzymes were active and the restriction sites were successfully incorporated 
into the TSA1 sequence. 
 
Figure 3.1 Genomic DNA was isolated from S. cerevisiae (A). TSA1 was PCR amplified 
from the genomic DNA (B), gel purified and ligated into pTZ57R/T and transformed into 
E. coli JM109 cells. The recombinant plasmids were then isolated from the cells and TSA1 
was PCR amplified from the plasmids to confirm the presence of the gene insert (C).  
For sub-cloning into pET28a, the restriction liberated TSA1 fragments together with 
double digested pET28a were gel purified. The purified TSA1 and pET28a fragments were 
then ligated using the Thermo Scientific Rapid Ligation Kit and transformed into 
E. coli BL21 cells which were made competent by calcium chloride treatment (Dagert and 
Ehrlich, 1979). The transformation efficiency was calculated as 2.81 x 103 CFU/µg of 
plasmid DNA. Plasmids were then isolated from two of the recombinant colonies and PCR 
confirmed that the TSA1 gene insert indeed was present in the plasmids (Figure 3.3). The two 
plasmid samples, named pBETSA1a and pBETSA1b were then sent for sequencing (Central 
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Analytical Facility, Stellenbosch University) and the inserts in both plasmids were 
determined to have 100% identity with the TSA1 sequence (NCBI, accession number 
NC_001145.3) by alignment with ClustalX2 (Figure 3.4). Thus TSA1 was successfully sub-
cloned into pET28a. The plasmid clones could now be used for the expression and 
purification of TSA1 for in vitro analysis. 
 
Figure 3.2 Restriction digestion of the isolated plasmids (pTTSA1a, pTTSA1b, pTTSA1c) 
for cloning of TSA1 into pTZ57R/T. Upon double digestion with NdeI and HindIII, the 
restriction liberated TSA1 gene insert could be visualised and sized. The size of insert was 
found to be 601bp. HindIII and NdeI double digested pET28a and TSA1 fragments were then 
gel extracted for sub-cloning of TSA1 into pET28a.  
 
Figure 3.3 PCR amplification of TSA1 from the isolated plasmids (pBETSA1a and 





Figure 3.4 Alignment of pBETSA1a and pBETSA1b plasmid clones with the TSA1 sequence (NCBI) to confirm the identity of the insert. (A) 
Promoter sequences were aligned with the TSA1 sequence and (B) terminator sequences were aligned with the TSA1 reverse compliment 
sequence (Blue highlight-alignment of cytosine and red highlight-alignment of adenine). 
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3.3.2 Expression of TSA1 and purification of the peroxiredoxin system proteins 
E. coli BL21 cells containing the plasmid clone pBETSA1a were induced with IPTG 
to express TSA1 using a high cell density method to maximise protein yield (Sivashanmugam 
et al., 2009). Samples of the cell culture were taken before addition of IPTG and after 
addition of IPTG, the protein concentration normalized against the culture optical density and 
analysed by SDS-PAGE to determine if the induced expression of TSA1 was successful 
(Figure 3.5). The resulting expressed protein was about the expected size of 23 kDa in a 
reducing SDS-PAGE gel. Sizing of the proteins was done using a standard curve generated 
by measuring the distance migrated from the well by each protein in the molecular weight 
marker. Stock cultures of the recombinant cells were made and frozen at -70ºC, available for 
use throughout the remainder of the project. 
 After protein induction, the recombinant E. coli BL21 cells were pelleted and 
sonicated in ice-cold extraction buffer to produce crude protein extract. Nickel affinity 
purification columns were used to purify His-tagged TSA1 protein from the crude protein 
extract and samples of the purified protein were run on a 13% Tris-Tricine acrylamide gel to 
confirm the purity of the protein samples (Figure 3.6). Contaminating bands were not 
observed on the SDS gel and therefore the proteins were sufficiently pure for the kinetic 
assays. Approximately 75 mg of TSA1 protein was purified from a 250 ml culture of 
recombinant E. coli BL21 cells. Thioredoxin reductase and thioredoxin were similarly 
expressed and purified with 65 mg (Figure 3.7) and 20 mg (Figure 3.8) of protein isolated per 
250 ml culture respectively.  
 
Figure 3.5 IPTG induced expression of TSA1 in recombinant E. coli BL21 cells. Samples 
were taken from the culture every hour for 5 hours after induction. The induced protein was 




Figure 3.6 Purification of His-tagged TSA1 protein from crude extract of IPTG-induced 
recombinant E.coli BL21 using Ni-NTA agarose bead resin. The beads were washed with 
buffer to remove contaminating proteins prior to elution with an imidazole containing 
buffer.  
 
Figure 3.7 Purification of his-tagged TRR1 protein from crude extract of IPTG-induced 
recombinant E.coli BL21 using Ni-NTA agarose bead resin. The protein was sized at 
35 kDa. The beads were washed with buffer to remove contaminating proteins prior to 




Figure 3.8 Purification of his-tagged TRX1 protein from crude extract of IPTG-induced 
recombinant E.coli BL21 using Ni-NTA agarose bead resin. The protein was sized at 
12 kDa. The beads were washed with buffer to remove contaminating proteins prior to 
elution with an imidazole containing buffer. 
3.4 Discussion 
 As previously discussed (Chapter 2.1), a number of assays have been established to 
determine peroxiredoxin activity (Nelson and Parsonage, 2011). The steady state system rate 
can be measured by monitoring NADPH oxidation as 340 nm, an assay requiring pure 
thioredoxin, thioredoxin reductase and peroxiredoxin proteins. Purchasing of these proteins 
would have been costly and expression plasmid clones for S. cerevisiae thioredoxin and 
thioredoxin reductase had previously been developed in our laboratory and were available for 
expression and purification of these proteins. The TSA1 gene was successfully cloned into 
pET28a (Figure 3.1-3.3) and its sequence was confirmed by DNA sequencing (Figure 3.4). 
TSA1 was then expressed (Figure 3.5) and purified (Figure 3.6) from recombinant E.coli 
BL21 cells. As peroxiredoxin, thioredoxin and thioredoxin reductase were required at high 
concentrations for the kinetic assays, a high density cell culture method (Sivashanmugam et 
al., 2009) was employed for overexpression of the proteins. Nickel affinity purification was 
then successfully used to purify the proteins from crude protein extract (Figure 3.6-3.7) with 
high yields determined for each protein (20-75 mg/250 ml culture) and these proteins were 





In vitro analysis of the peroxiredoxin system for validation of 
fitted kinetic parameters. 
4.1 Introduction 
 Computational modelling generated hypotheses about the different peroxiredoxin 
kinetic models and the necessity of whole system fitting for parameter determination due to 
the complexity of the peroxiredoxin system (Chapter 2). In vitro kinetic and computational 
analysis of the cytosolic TSA1 peroxiredoxin system from S. cerevisiae was then carried out 
to further verify these results. Initial modelling of the TSA1 peroxiredoxin system used 
parameters from the literature, for example a Km of 12 µM for hydrogen peroxide (Munhoz 
and Netto, 2004) and a second-order rate constant for hydrogen peroxide reduction of 2.2 
× 107 M−1 s−1 (Ogusucu et al., 2007). Modelling studies were complimented by in vitro 
kinetic studies in which the NADPH oxidation rate was monitored spectrophotometrically to 
generate datasets and the entire peroxiredoxin system were fitted to these datasets for 
parameter determination. 
A limitation of the NADPH-dependent assay is a lack of sensitivity in measuring the 
flux with low hydrogen peroxide concentrations (<20 µM) (Nelson and Parsonage, 2011) and 
therefore accurate hydrogen peroxide saturation datasets could not be reliably produced and 
instead thioredoxin and peroxiredoxin saturation datasets were determined. An additional 
consideration was that a decrease in the activity of His-tagged recombinant bovine 
peroxiredoxin due to a change in its native structure because of the presence of the His-tag 
had previously been reported (Cao et al., 2007; Barranco-Medina et al., 2009). Therefore, the 
activity of our recombinant TSA1 protein with and without the His-tag was tested and its 
conformation determined using Blue Native PAGE.  
4.2 Materials and Methods 
4.2.1 Materials 
Bovine serum albumin (BSA), dithiothreitol (DTT), 5,5′-dithio-bis (2-nitrobenzoic acid) 
(DTNB), NADPH, insulin from bovine pancreas, dialysis tubing (average flat width of 9 mm and 
25 mm) and the Thrombin CleanCleave™ Kit were obtained from Sigma (Kawasaki, Japan and 
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distributed by Capital Labs, South Africa). 30% Hydrogen peroxide was obtained from 
Laboratory and Analytical Supplies (Durban, South Africa) and stored at 4°C. All other common 
reagents such as EDTA were obtained from Saarchem (Merck, South Africa). TSA1, thioredoxin 
reductase and thioredoxin were purified as described in Chapter 3 and their extinction coefficients 
were determined using ProtParam (http://web.expasy.org/protparam/) as 24 075 M-1 cm-1, 24 660 
M-1 cm-1 and 10 095 M-1 cm-1, respectively . 
4.2.2 Computational modelling of the peroxiredoxin system from Saccharomyces 
cerevisiae 
Realistic modelling of peroxiredoxin activity and flux control analyses were 
undertaken as previously described (Chapter 2) using PySCeS with reaction parameters 
obtained from the literature and the species concentrations from our kinetic assays (Appendix 
2.3). Model fitting to our in vitro datasets used non-linear regression analysis (Chapter 2). 
4.2.3 Protein activity assays 
 The activity of purified peroxiredoxin was determined using a DTT peroxidase assay 
whereby the oxidation of DTT was monitored at 310 nm (Tairum et al., 2012) in a UV-1800 
Shimadzu spectrophotometer. Varying concentrations of purified TSA1 (1 µM, 2 µM and 
5 µM) were incubated with freshly prepared solutions of 10 mM DTT and 30 µM hydrogen 
peroxide in reaction buffer (25 mM potassium phosphate, 1 mM EDTA, 100 mM ammonium 
sulfate, pH 7.0) at 30°C in a 1 ml reaction volume for 10 minutes. A control sample was also 
measured that excluded TSA1 from the reaction and reactions were performed in triplicate. 
The absorbance at 310 nm was monitored and activity expressed as µM of DTT/min/mg of 
protein  
 The activity of thioredoxin reductase was determined by measuring the reduction of 
DNTB at 412 nm in an NADPH-dependent assay (Arner and Holmgren, 2001). Varying 
amounts of purified thioredoxin reductase (0.5 µM, 1 µM and 3 µM) were incubated with 
2.5 mM DTNB (50 mM stock solution was made up in absolute ethanol), 0.24 mM NADPH 
(from a 15 mM stock solution was made up in 0.01 M NaOH), 50 mM KCl, 10 mM EDTA, 
0.2 mg/ml BSA, and 500 mM NaCl in 500 mM potassium phosphate (pH 7.0) in a 1 ml 
reaction volume and was followed for 10 minutes. A control sample was also measured that 
excluded thioredoxin reductase from the reaction and reactions were performed in triplicate. 




 The activity of thioredoxin was determined using an insulin reduction assay measured 
by monitoring the change in absorbance at 650 nm (Arner and Holmgren, 2001). The reaction 
mixture was made up to a final volume of 1 ml containing 0.01 mM insulin from bovine 
pancreas, 2 mM EDTA, 1 mM DTT and 63 mM potassium phosphate buffer (pH 7.0) and 
purified thioredoxin protein (1 µM, 2 µM and 5 µM) and followed for 10 minutes. Insulin 
was prepared by suspending 50 mg of the peptide in 100 mM potassium phosphate buffer 
(pH 6.5) and adjusting the pH to 2-3 using concentrated HCl to dissolve the insulin. The pH 
was then readjusted to 6.5 using NaOH, made up to a final volume of 5 ml with ultrapure 
water to yield a 1.6 mM solution that was stored at -20°C. A control sample was also 
measured that excluded thioredoxin from the reaction and the reactions were performed in 
triplicate and the activity was expressed as ΔA650/min. 
4.2.4 Peroxiredoxin activity assay 
 Substrate saturation datasets with increasing thioredoxin concentrations were 
generated using fresh aliquots of purified protein and hydrogen peroxide and NADPH were 
prepared fresh daily. The concentration of diluted hydrogen peroxide solutions were verified 
using the extinction co-efficient of 43.6 M-1 cm-1 (Hildebraunt and Roots, 1975). The assays 
contained 150 µM NADPH, 5 µM thioredoxin, 0.5 µM thioredoxin reductase and 1 µM 
peroxiredoxin and reaction buffer (25 mM potassium phosphate, 1 mM EDTA, 100 mM 
ammonium sulfate, pH 7.0) in a 1 ml UV cuvette which was equilibrated at 25°C for 
5 minutes before the assay was initiated with the addition of 30 µM of hydrogen peroxide and 
followed for 5 minutes. In these assays, the thioredoxin concentration was ten times greater 
than thioredoxin reductase and five times greater than peroxiredoxin as recommended by 
Nelson and Parsonage (2011) to ensure that hydrogen peroxide reduction and not thioredoxin 
recycling was the rate-limiting step in the system.  
 A series of assays were performed with varied thioredoxin (0-15 µM) and 
peroxiredoxin concentrations (0.5, 1 and 2 µM) and control reactions were run 
simultaneously omitting the variable species in the reaction series. A minimum of eight 
concentrations were analysed per series and readings at each level were replicated at least 
three times. The reaction rate was determined from the initial linear portion of the curve using 
the extinction co-efficient for NADPH oxidation (ε340 = 6 220 M-1 cm-1). The activity of the 
control reaction was subtracted from each reaction in the series, final activity was determined 
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from an average of the replicates and standard errors are shown in the resulting figures unless 
otherwise stated. 
4.2.5 His-tag cleavage of TSA1  
 The Thrombin CleanCleave™ Kit from Sigma was used for cleavage of TSA1 His-
tags. TSA1 was initially dialysed with buffer (50 mM Tris-HCl, 10 mM CaCl2, pH 8.0) to 
remove any residual salts from purification which could inhibit cleavage. Thrombin resin 
(100 µl) was prepared by gentle centrifugation (500 × g, 2 minutes, RT) and removal of the 
supernatant. The resin was twice washed with 500 µl of 1 × Cleavage Buffer (50 mM Tris-
HCl, 10 mM CaCl2, pH 8.0) and finally resuspended in 10 × Cleavage Buffer (100µl, 
500 mM Tris-HCl, 100 mM CaCl2, pH 8.0). About 1 mg of protein was added to the reaction 
and topped up to a volume of 1 ml with distilled water. The reaction was incubated overnight 
while rotating (room temperature). A sample was then analysed on SDS-PAGE and at least 
95% was estimated to have been cleaved successful (data not shown, estimated from SDS 
gel). The remaining thrombin resin was removed from the sample by centrifugation (500 × g, 
2 minutes, RT) and the cleaved His-tags were removed by dialysis. The activity of the protein 
was then tested and compared to His-tagged protein.  
4.2.6 Blue native (BN) PAGE  
 In order to visualise the native form of TSA1, recombinant protein samples were run 
on a 4 to 13% native acrylamide gradient gel (Table 4.1, Wittig et al., 2006). Native gels 
were made up of acrylamide: bisacrylamide solution (48% (w/v) acrylamide, 1.5% (w/v) 
bisacrylamide, stored at 7°C), gel buffer (75 mM imidazole, pH 7.0), 100% (v/v) glycerol, 
distilled water and polymerisation was initiated with TEMED and freshly made 10% (w/v) 
ammonium persulfate for 30 minutes in the gel casting tray. The gel was poured in a gradient 
from a 13% to 4% acrylamide solution. The gradient gel was mixed and poured manually 
without the use of a peristaltic pump. Protein samples were prepared in loading buffer 
(5% (m/v) Coomassie blue G-250, 20% (v/v) glycerol, pH 7.0, stored at room temperature) 
immediately before loading of samples.  
Gels were run at constant 100 V until the samples entered the gel (~10 minutes) and 
then then switched to constant 15 mA until the blue dye front reached the bottom of the gel 
(~90 minutes at 4°C) using a cathode (50 mM Tricine, 7.5 mM imidazole, 0.02% (m/v) 
Coomassie blue G-250, pH 7.0) and anode buffer (25 mM imidazole, pH 7.0). Gels were 
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stained with Coomassie blue gel stain (0.125% (m/v) Coomassie brilliant blue R-250, 50% 
(v/v) methanol and 10% (v/v) acetic acid) overnight on a shaker, de-stained with de-stain 
solution I (45% (v/v) methanol, 9% (v/v) glacial acetic acid) until the background was clear 
and finally placed in de-stain solution II (5% (v/v) methanol, 7% (v/v) acetic acid) to 
rehydrate and store the gel. Gels were photographed under white light using a DNR MiniBIS 
Pro Versadoc.  
Table 4.1 BN-PAGE gradient gel mixtures for visualising native proteins. 
 4% Acrylamide Gel 13% Acrylamide Gel 
 Volume (ml) 
Water 10.4 3 
Acrylamide: Bisacrylamide Solution 1.5 3.9 
Gel Buffer  6 5 
Glycerol - 3 
TEMED 0.010 0.0075 
10% Ammonium persulfate 0.1 0.075 
Total Volume 18 15 
 
4.3 Results 
4.3.1 Comparison of the activity of His-tagged and His-tag cleaved TSA1 protein 
Previous analysis of bovine peroxiredoxin 3 found that the presence of His-tags could 
negatively affect recombinant C-terminus tagged protein activity (Cao et al., 2007; Barranco-
Medina et al., 2009) and therefore His-tags were subsequently cleaved from our recombinant 
N-terminal tagged TSA1 in this study and compared to the activity of His-tagged protein 
(Figure 4.1). His-tagged and His-tag cleaved protein activities were measured at similar rates 
of 2.1 × 105 M.s−1 and 2.0 × 105 M.s−1 respectively showing that the N-terminal tag did not 
dramatically affect peroxiredoxin activity. 
TSA1 predominantly forms monomers at 23 kDa on a reducing SDS gel and 
homodimers at 46 kDa on a non-reducing SDS gel but is present as a decamer in vivo (De 
Oliveira et al., 2007; Tairum et al., 2012). Purified TSA1 was run on one-dimensional BN-
PAGE gels to visualise the native form of this protein (Figure 4.2, Wittig et al., 2006). BN-
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PAGE omits detergents such as SDS that dissociate proteins in typical protein electrophoresis 
and instead Coomassie blue dye is used to resolve the proteins by suppling a charge to allow 
them to separate according to size in their native form. A decameric form of peroxiredoxin 
was sized at about 210 kDa (Standard curve, Appendix 2.3.3) close to an expected size of 220 
kDa, while no lower molecular weight forms were observed. A second multimeric structure 
was also observed at a higher molecular weight than the decamer but was outside the range of 
the molecular weight marker and this is presumably a high molecular weight isoform that has 
been reported to have chaperone activity (Barranco-Medina et al., 2009; Cao et al., 2015; 
Radjainia et al., 2015). The native form of the recombinant peroxiredoxin was therefore 
determined to be primarily a decameric structure, in agreement with published studies of 
other peroxiredoxins (De Oliveira et al., 2007; Tairum et al., 2012) and was not affected by 
the presence of an N-terminal His-tag. 
 
Figure 4.1 Comparison of the activity of His-tagged ( ) and His-tag cleaved ( ) TSA1 
protein in an NADPH-dependent assay. The assay was carried out with 150 µM NADPH, 
5 µM thioredoxin, 0.5 µM thioredoxin reductase, 2 µM peroxiredoxin and 30 µM hydrogen 
peroxide in reaction buffer pH 7.0. The results are representative of three replicate 
































Figure 4.2 BN-PAGE of TSA1 protein revealed two high molecular weight structures of the 
protein. A non-denaturing PAGE kit (Sigma) for molecular weights 14 kDa – 272 kDa and 
cytochrome C (12.3 kDa) were used to generate a standard curve for sizing of TSA1.  
4.3.2 Data fitting of the models to a thioredoxin substrate saturation dataset for 
parameter determination 
 The proposed peroxiredoxin models were simulated with increasing thioredoxin 
concentrations, using kinetic parameters from the literature (Table 4.2) and compared to an in 
vitro dataset generated using a peroxiredoxin concentration of 1 µM (Table 4.3). While one 
parameter used in the modelling experiment was obtained from recycling of the E.coli Tpx 
system, the rate constant for peroxiredoxin reduction is in a similar range for all 
peroxiredoxins and the reaction conditions of our experiment were developed so that 
hydrogen peroxide reduction should have been rate-limiting (Nelson and Parsonage, 2011). 
As with previous analyses (Chapter 2), all the models revealed distinct responses and failed 
to reproduce the in vitro dataset (Figure 4.3) confirming that some parameters reported in the 
literature should be used with caution when developing models of the peroxiredoxin system. 
The peroxiredoxin kinetic models were then fitted to the in vitro dataset to estimate 
parameters for the system, the ping-pong enzyme and redox couple monomer models were 
able to fit the in vitro dataset (r2 value = 0.98, Table 4.4) but attempts at fitting the redox 
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couple homodimer model were unsuccessful and therefore this model was excluded from 
further analysis.  
Table 4.2 Reactions and reaction parameters for computational modelling of the TSA1 
peroxiredoxin system from S. cerevisiae. 
Reaction Parameter Value Reference 
All Models 
R1: NADPH + TrxSS → NADP+ + TrxSH 
kcat 1 66 s-1 (Speranza et al., 
1973) 
 Knadph 1.2 µM (Williams Jr, 1976) 
 Ktrxss 4.4 µM (Williams Jr, 1976) 
Ping-Pong Enzyme Model 







(Munhoz and Netto, 
2004) 
Redox Couple Monomer Model 
R2: H2O2 + PrxSH → H2O + PrxSS 
k2 
22 μM-1 s-1 
(Ogusucu et al., 
2007) 
R3: PrxSS + TrxSH → PrxSH + TrxSS k3 3 μM-1 s-1 a 
Redox Couple Homodimer Model 
R2: PrxSHPrxSH + H2O2 → PrxSSPrxSH + 
H2O 
k2 22 μM-1 s-1 (Ogusucu et al., 
2007) 
R3: PrxSSPrxSH + H2O2 → PrxSSPrxSS + 
H2O 
k2 22 μM-1 s-1 (Ogusucu et al., 
2007) 
R4: PrxSSPrxSS + TrxSH → PrxSSPrxSH + 
TrxSS 
k3 3 μM-1 s-1 a 
R5: PrxSSPrxSH + TrxSH →PrxSHPrxSH + 
TrxSS 
k3 3 μM-1 s-1 a 
  a parameters obtained for E.coli Tpx system (Baker and Poole, 2003).  
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Table 4.3 Species concentrations of the various system components used in each model for 
realistic modelling of the TSA1 peroxiredoxin system from S. cerevisiae. 










Ping-Pong Enzyme Prx 1 








*Note that the total concentration (reduced and oxidised) of all moiety conserved species is 




Figure 4.3 The three peroxiredoxin activity models produced a different response with 
parameters from the literature to the in vitro dataset generated with increasing thioredoxin 
concentrations. The assays were carried out with 150 µM NADPH, 5 µM thioredoxin, 0.5 
µM thioredoxin reductase and 1 µM peroxiredoxin and 30 µM hydrogen peroxide in a 
reaction buffer (pH 7.0). The results are representative of three replicate experiments and 
where standard errors are not visible they are smaller than the symbol (n=3). 
 Second order rate constants for hydrogen peroxide reduction of 4.4 × 105 M-1 s-1 and 
5.1 × 103 M-1 s-1 were determined for the ping-pong enzyme (kcat/Km) and redox couple 
monomer models respectively. As with the earlier fitting experiments (Chapter 2), these 
parameters were smaller than the rate constant of 107 M-1 s-1 determined by a competition 
assay with horse radish peroxidase (Ogusucu et al., 2007). The rate constant of 103 M-1 s-1 
fitted for the redox couple monomer model was also consistent with the fitted rate constants 
determined with the fitted human erythrocyte peroxiredoxin 2 and C. crescentus periplasmic 
peroxiredoxin models (Chapter 2). To test the accuracy of the resulting fitted models, two 
independent in vitro datasets were generated with varying thioredoxin concentrations and 
peroxiredoxin concentrations of 0.5 µM and 2 µM and compared to simulations of the fitted 
models (Figure 4.4). The ping-pong enzyme and redox couple monomer models were able to 
reasonably predict the datasets and showed near identical responses to changes in the 
thioredoxin and peroxiredoxin concentrations (Figure 4.4).  
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To differentiate these kinetic models, the fitted models were then used to simulate 
additional datasets with increasing thioredoxin reductase and peroxiredoxin concentrations 
(Figure 4.5) and the redox state of thioredoxin was monitored (Figure 4.6). Similarities were 
observed between the models suggesting these in vitro datasets could be reasonably described 
by either the ping-pong enzyme or redox couple monomer models.  
Table 4.4 Parameters determined by fitting of the peroxiredoxin activity models to an in vitro 
dataset with increasing thioredoxin concentrations using non-linear regression analysis.  
Parameter Value Fitted Curve 
Ping-Pong Enzyme Model 
 
(Note: ping-pong enzyme and redox couple monomer fitted 
models datasets overlap) 
k cat 2 (Prx) 0.156 s-1 
KH2O2 0.358 µM 
KTrxSH 0.996 µM 
r2 0.98 
Redox Couple Monomer Model 
k2 5.1 × 103 M-1 s-1 







Figure 4.4 Fitted peroxiredoxin kinetic models based on the ping-pong (A) and redox couple 
mechanisms (B) can predict independent in vitro datasets. Steady state assays were carried 
out with 150 µM NADPH, 0.5 µM thioredoxin reductase, 30 µM hydrogen peroxide in a 
reaction buffer pH 7.0 at varying thioredoxin (0-15 µM) and peroxiredoxin (0.5, 1 and 2 µM) 
concentrations. The standard errors for the datasets are shown (n=3). 
 
Figure 4.5 The fitted ping-pong enzyme and redox couple monomer models show similar 
responses to increasing thioredoxin reductase (A) and peroxiredoxin concentrations (B). The 




Figure 4.6 Simulation of the fitted ping-pong enzyme and redox couple monomer models 
yielded similar predictions on the redox state of thioredoxin with increasing thioredoxin 
reductase (A), peroxiredoxin (B) and hydrogen peroxide concentrations (C). The ping-pong 
enzyme and redox couple monomer model datasets overlap in (A), (B) and (C). 
 Despite their similar properties, the ping-pong enzyme and redox couple monomer 
models had a 100-fold difference in the fitted rate constants for hydrogen peroxide reduction 
(Table 4.4). The models were simulated with increasing hydrogen peroxide and saturated the 
system at very low hydrogen peroxide concentrations in the ping-pong enzyme model, while 
the rate continued to gradually increase throughout this range of concentrations in the redox 
couple monomer model (Figure 4.7). This result showed that these kinetic models do indeed 
yield distinct predictions but this could not be confirmed in vitro due to the rapid depletion of 
hydrogen peroxide in the steady state NADPH oxidation assay. Modification of the assay at 
low hydrogen peroxide concentrations or use of a more sensitive spectrophotometer is needed 




Figure 4.7 The fitted ping-pong enzyme and redox couple monomer models showed distinct 
responses to increasing hydrogen peroxide concentrations.  
4.3.3 Flux control patterns of the fitted Saccharomyces cerevisiae peroxiredoxin kinetic 
models. 
 Flux control for both models lay primarily with the hydrogen peroxide reduction step 
(Table 4.5) suggesting that this reaction was indeed rate-limiting in the system. The flux 
control pattern in the fitted ping-pong enzyme model was consistent with the human 
erythrocyte peroxiredoxin 2, C. crescentus peroxiredoxin and S. cerevisiae TSA1 systems 
(Tables 2.8, 2.10 and 4.5). In the fitted redox couple monomer models, the peroxiredoxin 
recycling reaction had primary flux control for the human erythrocyte peroxiredoxin 2 and C. 
crescentus peroxiredoxin systems although the species concentrations used in these 
experiments were not necessarily chosen so that hydrogen peroxide recycling was rate-
limiting (Manta et al., 2009; Cho et al., 2012). Determining the flux control coefficient in the 
fitted redox couple monomer models with varying thioredoxin concentrations showed that the 
thioredoxin concentration used to produce the human erythrocyte peroxiredoxin 2 and C. 
crescentus periplasmic peroxiredoxin in vitro datasets was too low for the hydrogen reduction 
reaction to have primary flux control (Figure 4.8) but was sufficient in our S. cerevisiae in 
vitro datasets. Determining the relative concentrations of reactants needed to ensure a given 
reaction is rate-limiting in a peroxiredoxin steady state assay is therefore complex and 
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suggests that fitting all reactions in a computational model is necessary for analysing such 
complex systems. 
Table 4.5 Comparison of flux control coefficients for each reaction in the peroxiredoxin 




Ping-Pong Enzyme Model 
1 CR1
JR1 = 0.0006 
CR2
JR1 = 0.9994 NADPH + TrxSS → NADP+ + TrxSH 
2 𝐶𝑅1
𝐽𝑅1 = 0.0006 
𝐶𝑅2
𝐽𝑅1 = 0.9994 TrxSH + H2O2 → TrxSS + H2O 
Redox Couple Monomer Model 
1 𝐶𝑅1
𝐽𝑅1= 0.001 
NADPH + TrxSS → NADP+ + TrxSH CR2





H2O2 + PrxSH → H2O + PrxSS 𝐶𝑅2





PrxSS + TrxSH → PrxSH + TrxSS 𝐶𝑅2
𝐽𝑅1 = 0.836 
 𝐶𝑅3
𝐽𝑅1= 0.163 




Figure 4.8 Flux control in the fitted redox couple monomer models was determined with 
varying thioredoxin concentrations for the human erythrocyte peroxiredoxin 2 (A), 
C. crescentus peroxiredoxin (B) and S. cerevisiae TSA1 (C) peroxiredoxin systems. At lower 
thioredoxin concentrations, peroxiredoxin reduction (reaction 3) was rate-limiting but as its 
concentration increased hydrogen peroxide reduction (reaction 2) became rate-limiting.  
4.4 Discussion 
In most kinetic studies of the peroxiredoxin system, the kinetic parameters for 
hydrogen peroxide reduction were obtained with either an in vitro steady state, competition or 
direct peroxiredoxin oxidation assay. Initial modelling studies using all three peroxiredoxin 
models with parameters from the literature failed to reproduce an in vitro dataset generated 
during this study (Figure 4.3) and therefore a different experimental strategy was pursued in 
which the entire peroxiredoxin system was fitted to steady state in vitro datasets (Table 4.4). 
The parameters obtained from these fitting experiments were then verified for accuracy by 
comparing the fitted models to independent in vitro datasets with varying thioredoxin and 
peroxiredoxin concentrations. Attempts at fitting of the redox couple homodimer model 
failed while the ping-pong enzyme and redox couple monomer models determined fitted rate 
constants for hydrogen peroxide reduction in the range of 105 (kcat/Km ratio) and 103 M-1 s-1 
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respectively and not the rate of 107 M-1 s-1 previously measured for TSA1 in a competition 
assay (Ogusucu et al., 2007). This rate constant is consistent with range determined through 
fitting for human erythrocyte peroxiredoxin 2 and C. crescentus peroxiredoxin dataset 
(Chapter 2). Using the parameters determined by data fitting, the ping-pong enzyme and 
redox couple monomer models were successfully able to reproduce two independent in vitro 
datasets (Figure 4.4). The fitted models (Figure 4.5 and 4.6) also showed similar flux and 
thioredoxin redox state responses to increasing thioredoxin reductase and peroxiredoxin 
concentrations, suggesting that these fitted kinetic models could be used interchangeably for 
this set of experimental conditions. The ability of these fitted models to reproduce 
independent datasets validated the fitting strategy used to determine these parameters. Core 
computational modelling suggested that changes to the thioredoxin reductase and 
peroxiredoxin concentrations should have been able to distinguish the models (Chapter 2) but 
our experiments yielded similar responses with the fitted models (Figure 4.5 and 4.6). 
Unfortunately, the 100-fold difference in the hydrogen peroxide reduction rate constant 
between the ping-pong enzyme and redox couple monomer models (Figure 4.7) could not be 
investigated in this study due to the difficulty measuring rates with low hydrogen peroxide 
concentrations that quickly depleted. Further analysis could use stopped-flow 
spectrophotometry or the flux in the assay could be reduced by lower thioredoxin reductase 
or NADPH concentrations. Fitting of the redox couple homodimer could also be re-attempted 
on this dataset or possibly other datasets that are generated.  
 Flux control analysis showed that even with careful selection of reactant 
concentrations, assigning a rate-limiting step in the peroxiredoxin kinetic models is difficult 
(Table 4.5 and Figure 4.8). For example, in the redox couple monomer model, the ratio of 
thioredoxin to thioredoxin reductase in the assay appears to determine if hydrogen peroxide 
reduction will be the rate-limiting reaction in the system but the ratio required varied between 
the different peroxiredoxin systems tested which can be challenging for setting up in vitro 
assays. This result also argued that using whole system data fitting may be the most accurate 
method for parameter determination in the peroxiredoxin system.  
An argument for the redox couple monomer model compared to the ping-pong 
enzyme model is that data about the oxidised and reduced peroxiredoxin concentrations can 
be obtained from this model. These concentrations can be quantified using redox Western 
blotting analysis with anti-peroxiredoxin antibodies which already have been generated in the 
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laboratory and will be purified in future studies so that this experiment can be undertaken 






Hydrogen peroxide is a metabolic by-product associated with oxidative stress but has 
also recently been found to initiate redox signalling processes at physiological concentrations 
(Veal et al., 2007; Finkel, 2011; Veal and Day, 2011). Peroxiredoxins appear to mediate the 
balance between hydrogen peroxide detoxification and signal transduction (Jarvis et al., 
2012; Randall et al., 2013; Perkins et al., 2015; Sobotta et al., 2015). Understanding the 
precise role of peroxiredoxins in these processes is difficult as these processes are complex 
and therefore the use of systems biology tools is necessary. Unfortunately three different 
peroxiredoxin kinetic models have proposed and used interchangeably in computational 
analyses of peroxiredoxin activity (Table 1.1, Figure 1.6). The rate constants for hydrogen 
peroxide reduction have also varied depending on the method used to measure this parameter 
and it is unclear which constants should be used in computational models (Section 2.1). 
Collectively, these discrepancies have limited the use of systems biology tools to further our 
understanding of peroxiredoxin activity.  
Core computational modelling of the peroxiredoxin kinetic models determined 
different behaviours in terms of the flux and steady state thioredoxin concentrations in 
response to parameter changes and therefore these models were distinct and should not be 
used interchangeably (Section 2.3.1). These results were confirmed using in vitro 
computational analyses of the human erythrocyte peroxiredoxin 2 and C. crescentus 
peroxiredoxin systems (Section 2.3.2 and 2.3.4) and therefore a precise description of the 
peroxiredoxin system is needed for systems biology studies. Further, the effect of parameter 
changes on the steady state thioredoxin concentrations could be as an important system 
output to distinguish the peroxiredoxin kinetic models. The modelling also revealed the 
difficulty in determining the rate-limiting step for in vitro assays due to the complex flux 
control pattern of the peroxiredoxin system (Section 2.3.3 and 2.3.5). Determining the rate-
limiting step was not necessary in this study however, as the rate constants for hydrogen 
peroxide reduction (103-105 M-1 s-1) were determined by whole system fitting to in vitro 
datasets and these constants were much lower than those determined by competition assay. 
To confirm these results, the S. cerevisiae TSA1 system was cloned, expressed and 
purified in large amounts using a high yield expression protocol (Sivashanmugam et al., 
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2009) for in vitro analysis of this system (Chapter 3). In our hands, the recombinant His-
tagged TSA1 activity was similar to the His-tag cleaved TSA1 and the protein conformation 
was predominantly decameric (Section 4.3.1, De Oliveira et al., 2007; Tairum et al., 2012). 
An in vitro dataset was generated and whole system data fitting was again used to determine 
kinetic parameters, which unlike other studies, were then verified by predicting independent 
datasets with varying thioredoxin and peroxiredoxin concentrations (Chapter 4). While the 
ping-pong enzyme and redox couple monomer models could fit and predict these datasets, the 
redox couple homodimer model failed to fit all datasets produced in this study. Interestingly 
the redox couple homodimer kinetic model has been used in a comprehensive model of 
hydrogen peroxide metabolism in red blood cells (Benfeitas et al., 2014). We speculate that 
the failure of this kinetic model for the TSA1 peroxiredoxin system is due to conformational 
changes occurring during peroxiredoxin catalysis. In some peroxiredoxins, oxidation of the 
peroxidatic cysteine triggers structural changes in the peroxiredoxin dimer interface which 
obscures the second active site causing decamer dissociation (Parsonage et al., 2005; Hall et 
al., 2010). Thus, the stoichiometry of this reaction involves the reduction of a single 
hydrogen peroxide per catalytic cycle. The redox couple homodimer model was therefore 
excluded from further analysis while the fitted ping-pong enzyme and redox couple monomer 
models produced similar responses to almost all parameter changes and therefore both appear 
to be applicable to the TSA1 peroxiredoxin system. The flux response with increasing 
hydrogen peroxide concentrations was the only difference between these two fitted kinetic 
models and a modification of the in vitro assay in future studies could distinguish these 
models.  
As with the human erythrocyte peroxiredoxin 2 and C. crescentus peroxiredoxin 
systems, the hydrogen peroxide reduction rate constants for the fitted TSA1 kinetic models 
was also in the range of 103-105 M-1 s-1 which suggests that peroxiredoxin recycling is 
important for hydrogen peroxide reduction and the thioredoxin redox couple can affect 
peroxiredoxin activity. In addition, this lower estimate for hydrogen peroxide reduction rate 
constant is in agreement with the kinetics of hydrogen peroxide signalling. For example, 
glutathione peroxidase-like protein 3 (Gpx3), must compete with TSA1 for hydrogen 
peroxide in order to oxidise the transcription factor YAP1 (Ghaemmaghami et al., 2003; 
Tachibana et al., 2009). The concentrations of Gpx3 and Yap1 are several orders lower than 
TSA1 and TSA1 with a purported rate constant of 107 M-1 s-1 (Ogusucu et al., 2007) should 
easily outcompete Gpx3 for hydrogen peroxide. However, YAP1 is still activated at 0.1 mM 
77 
 
hydrogen peroxide in vivo (Delaunay et al., 2002) suggesting that the peroxiredoxin rate 
constants of 106-108 M-1 s-1 obtained by the competition assay may be a severe overestimate.  
 In summary, the work in this thesis has confirmed that the kinetic models used to 
describe peroxiredoxin activity can yield computational models with distinct properties. In 
future studies, we plan to use redox Western blotting and a modified kinetic assay to 
distinguish the ping-pong enzyme and redox couple monomer models. The second major 
outcome is that the rate constants for hydrogen peroxide reduction by peroxiredoxins may 
need to be reviewed. This work emphasises how the kinetic linkages within the peroxiredoxin 
system are as important as the reaction of hydrogen peroxide and peroxiredoxin. With revised 
peroxiredoxin kinetic models, insight may be found into the multitude of diseases associated 
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1. Core computational Models 
1.1 Peroxiredoxin Activity Models with Core Parameters 
 
#Core Peroxiredoxin Activity Model - Ping-pong enzyme model 
 
FIX: NADPH NADP H2O2 H2O 
 




R2: TrxSH + H2O2 = TrxSS + H2O 
(kcat2*Prx*(TrxSH/Ktrxsh)*(H2O2/K1h2o2))/((H2O2/K1h2o2)+(TrxSH
/Ktrxsh)+((TrxSH/Ktrxsh)*(H2O2/K1h2o2))) 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 =1 
TR = 1 
Knadph = 1 
K1trxss = 1 
 
kcat2 = 1 
Prx = 1 
Ktrxsh = 1 
K1h2o2 = 1 
 
#Species concentrations - units in µM 
 
NADPH = 1 
NADP = 1 
TrxSS = 0.5 
TrxSH = 0.5 
H2O2 = 1 





#Core Peroxiredoxin Activity Model - Redox couple monomer 
model 
 
FIX: NADPH NADP H2O2 H2O 
 




R2: H2O2 + PrxSH = H2O + PrxSS 
k2*H2O2*PrxSH 
 
R3: PrxSS + TrxSH = PrxSH + TrxSS 
k3*PrxSS*TrxSH 
 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 =1 
TR = 1 
Knadph = 1 
K1trxss = 1 
 
k2 = 1 
 
k3 = 1 
 
#Species concentrations - units in µM 
 
NADPH = 1 
NADP = 1 
TrxSS = 0.5 
TrxSH = 0.5 
H2O2 = 1 
H2O = 1 
PrxSH = 0.5 
PrxSS = 0.5 
  
 
#Core Peroxiredoxin Activity Model - Redox couple homodimer 
model 
 
FIX: NADPH NADP H2O2 H2O 
 




R2: PrxSHPrxSH + H2O2 = PrxSSPrxSH + H2O 
k2*PrxSHPrxSH*H2O2*2 
 
R3: PrxSSPrxSH + H2O2 = PrxSSPrxSS + H2O 
k2*PrxSSPrxSH*H2O2 
 
R4: PrxSSPrxSS + TrxSH = PrxSSPrxSH + TrxSS 
k3*PrxSSPrxSS*TrxSH*2 
 
R5: PrxSSPrxSH + TrxSH = PrxSHPrxSH + TrxSS 
k3*PrxSSPrxSH*TrxSH 
 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
#Species concentrations - units in µM 
 
kcat1 = 1 
TR = 1 
Knadph = 1 
K1trxss = 1 
 
 
k2 = 1 
k3 = 1 
 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
#Species concentrations - units in µM 
 
NADPH = 1 
NADP = 1 
TrxSS = 0.5 
TrxSH = 0.5 
H2O2 = 1 
H2O = 1 
PrxSHPrxSH = 0.33 
PrxSSPrxSH = 0.33 





1.2 Modelling Scripts  
 
#Core modelling of the peroxiredoxin system 
 
#import the operating system 
import os 
#tell opertaing system get the current working directory (cwd) 
and call the cwd backupdir 
backupdir = os.getcwd() 







#tell PySCeS to look for the psc files in the current folder. 
pysces.PyscesModel.MODEL_DIR=backupdir 
pysces.PyscesModel.OUTPUT_DIR=backupdir 
#tell opertaing system to work in the current directory 
os.chdir(backupdir) 
#need to call the plotting programme called matplotlib and 
pylab. 
#from pylab get stuff to doplotting 
from pylab import figure, ioff, plt, subplots_adjust, rcParams 
rcParams['mathtext.fontset']='stixsans' 
pylab.rc('font', serif='Ariel') 
from matplotlib.pyplot import* 
#from numpy import arrange 
 
matplotlib.rcParams.update({'font.size':12}c) 
pylab.rc('xtick', labelsize = 12) 
pylab.rc('ytick', labelsize = 12) 
pylab.rc('ytick.major', pad = 12) 
pylab.rc('ytick.minor', pad = 12) 
pylab.rc('axes', labelsize = 12) 
#from matplot lib get everything (*) 




m.scan_in = 'TR' 
m.scan_out=['J_R1', 'Prx', 'TrxSH_ss', 'TrxSS_ss'] 





n.scan_in = 'TR' 
 
n.scan_out=['J_R1', 'PrxSH_ss', 'PrxSS_ss', 'TrxSH_ss', 
'TrxSS_ss'] 





o.scan_in = 'TR' 
o.scan_out=['J_R1', 'PrxSHPrxSH_ss', 'PrxSSPrxSS_ss', 
'PrxSSPrxSH_ss', 'TrxSH_ss', 'TrxSS_ss'] 






m.scan_in = 'H2O2' 
m.scan_out=['J_R1', 'Prx', 'TrxSH_ss', 'TrxSS_ss'] 






n.scan_in = 'H2O2' 
n.scan_out=['J_R1', 'PrxSH_ss', 'PrxSS_ss', 'TrxSH_ss', 
'TrxSS_ss'] 






o.scan_in = 'H2O2' 
o.scan_out=['J_R1', 'PrxSHPrxSH_ss', 'PrxSSPrxSS_ss', 
'PrxSSPrxSH_ss', 'TrxSH_ss', 'TrxSS_ss'] 






m.scan_in = 'H2O2' 
m.scan_out=['J_R1', 'Prx', 'TrxSH_ss', 'TrxSS_ss'] 






n.scan_in = 'H2O2' 
 
n.scan_out=['J_R1', 'PrxSH_ss', 'PrxSS_ss', 'TrxSH_ss', 
'TrxSS_ss'] 






o.scan_in = 'H2O2' 
o.scan_out=['J_R1', 'PrxSHPrxSH_ss', 'PrxSSPrxSS_ss', 
'PrxSSPrxSH_ss', 'TrxSH_ss', 'TrxSS_ss'] 








m.scan_in = 'TrxSH_init' 
m.scan_out=['J_R1', 'Prx', 'TrxSH_ss', 'TrxSS_ss'] 







n.scan_in = 'TrxSH_init' 
n.scan_out=['J_R1', 'PrxSH_ss', 'PrxSS_ss', 'TrxSH_ss', 
'TrxSS_ss'] 








o.scan_in = 'TrxSH_init' 
o.scan_out=['J_R1', 'PrxSHPrxSH_ss', 'PrxSSPrxSS_ss', 
'PrxSSPrxSH_ss', 'TrxSH_ss', 'TrxSS_ss'] 






m.scan_in = 'Prx' 
m.scan_out=['J_R1', 'Prx', 'TrxSH_ss', 'TrxSS_ss'] 









n.scan_in = 'PrxSH_init' 
n.scan_out=['J_R1', 'PrxSH_ss', 'PrxSS_ss', 'TrxSH_ss', 
'TrxSS_ss'] 









o.scan_in = 'TrxSH_init' 
o.scan_out=['J_R1', 'PrxSHPrxSH_ss', 'PrxSSPrxSS_ss', 
'PrxSSPrxSH_ss', 'TrxSH_ss', 'TrxSS_ss'] 









#plot of the change in flux of all models as thioredoxin 
reductase increases 
ax = subplot(4,4,1) 
ax.plot(g[:,0],g[:,1], 'k-', label='Rate') 
ax.plot(h[:,0],h[:,1], 'r-', label='Rate') 
ax.plot(i[:,0],i[:,1], 'b-', label='Rate') 
ax.set_xlabel(r' Thioredoxin Reductase($\mu$M)') 
ax.set_ylabel(r' Flux ($\mu$M s $^{-1}$)') 
 
#plot of the change in flux of all models as hydrogen peroxide 
increases 
ax = subplot(4,4,3) 
ax.plot(xx[:,0],xx[:,1], 'k-', label='Rate') 
ax.plot(yy[:,0],yy[:,1], 'r-', label='Rate') 
ax.plot(zz[:,0],zz[:,1], 'b-', label='Rate') 
ax.set_xlabel(r'Hydrogen Peroxide ($\mu$M)') 
ax.set_ylabel(r' Flux ($\mu$M s $^{-1}$)') 
 
#plot of the change in flux of all models as thioredoxin 
increases 
 
ax = subplot(4,4,2) 
ax.plot(r[:,0],r[:,1], 'k-', label='Rate') 
ax.plot(s[:,0],s[:,1], 'r-', label='Rate') 
ax.plot(t[:,0],t[:,1], 'b-', label='Rate') 
ax.set_xlabel(r' Thioredoxin ($\mu$M)') 
ax.set_ylabel(r' Flux ($\mu$M s $^{-1}$)') 
 
#plot of the change in flux of all models as peroxiredoxin 
increases 
ax = subplot(4,4,4) 
ax.plot(aa[:,0],aa[:,1], 'k-', label='Rate') 
ax.plot(bb[:,0],bb[:,1], 'r-', label='Rate') 
ax.plot(cc[:,0],cc[:,1], 'b-', label='Rate') 
ax.set_xlabel(r' Peroxiredoxin ($\mu$M)') 
ax.set_ylabel(r' Flux ($\mu$M s $^{-1}$)') 
 
#Log Plots 
#plot of the change in flux of all models as thioredoxin 
reductase increases 
ax = subplot(4,4,5) 
ax.loglog(g[:,0],g[:,1], 'k-', label='Rate') 
ax.loglog(h[:,0],h[:,1], 'r-', label='Rate') 
ax.loglog(i[:,0],i[:,1], 'b-', label='Rate') 
ax.set_xlabel(r' Thioredoxin Reductase($\mu$M)') 
ax.set_ylabel(r' Flux ($\mu$M s $^{-1}$)') 
 
#plot of the change in flux of all models as hydrogen peroxide 
increases 
ax = subplot(4,4,7) 
ax.loglog(x[:,0],x[:,1], 'k-', label='Rate') 
ax.loglog(y[:,0],y[:,1], 'r-', label='Rate') 
ax.loglog(z[:,0],z[:,1], 'b-', label='Rate') 
ax.set_xlabel(r'Hydrogen Peroxide ($\mu$M)') 
ax.set_ylabel(r' Flux ($\mu$M s $^{-1}$)') 
 
#plot of the change in flux of all models as thioredoxin 
increases 
ax = subplot(4,4,6) 
ax.loglog(r[:,0],r[:,1], 'k-', label='Rate') 
ax.loglog(s[:,0],s[:,1], 'r-', label='Rate') 
ax.loglog(t[:,0],t[:,1], 'b-', label='Rate') 
ax.set_xlabel(r' Thioredoxin ($\mu$M)') 
ax.set_ylabel(r' Flux ($\mu$M s $^{-1}$)') 
 
#plot of the change in flux of all models as peroxiredoxin 
increases 
ax = subplot(4,4,8) 
ax.loglog(aa[:,0],aa[:,1], 'k-', label='Rate') 
ax.loglog(bb[:,0],bb[:,1], 'r-', label='Rate') 
ax.loglog(cc[:,0],cc[:,1], 'b-', label='Rate') 
ax.set_xlabel(r' Peroxiredoxin ($\mu$M)') 
 









2. Realistic Computational Modelling 
2.1 Human erythrocyte peroxiredoxin 2  
2.1.1 Model Files 
 
#Realistic modelling of the peroxiredoxin system-Human 
Peroxiredoxin 2 
 
#Ping-pong enzyme model 
 
FIX: NADPH NADP H2O2 H2O 
 








#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 =25.78 
TR = 1 
Knadph = 6 
K1trxss = 1.83 
 
kcat2 = 13.2 
Prx = 0.5 
Ktrxsh = 3.24 
K1h2o2 = 0.7 
 
#Species concentrations - units in µM 
 
NADPH = 200 
NADP = 1 
TrxSS = 1 
TrxSH = 1 
H2O2 = 30 
H2O = 1 
  
 
#Realistic modelling of the peroxiredoxin system-Human 
Peroxiredoxin 2 
 
#Redox couple monomer model 
 
FIX: NADPH NADP H2O2 H2O 
 




R2: H2O2 + PrxSH = H2O + PrxSS 
k2*H2O2*PrxSH 
 
R3: PrxSS + TrxSH = PrxSH + TrxSS 
k3*PrxSS*TrxSH 
 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 =25.78 
TR = 1 
Knadph = 6 
K1trxss = 1.83 
 
k2 = 100 
 
k3 = 0.074 
 
#Species concentrations - units in µM 
 
NADPH = 200 
NADP = 1 
TrxSS = 1 
TrxSH = 1 
H2O2 = 30 
H2O = 1 
PrxSH = 0.25 





#Realistic modelling of the peroxiredoxin system-Human 
Peroxiredoxin 2 
 
#Redox couple homodimer model  
 
FIX: NADPH NADP H2O2 H2O 
 




R2: PrxSHPrxSH + H2O2 = PrxSSPrxSH + H2O 
k2*PrxSHPrxSH*H2O2*2 
 
R3: PrxSSPrxSH + H2O2 = PrxSSPrxSS + H2O 
k2*PrxSSPrxSH*H2O2 
 
R4: PrxSSPrxSS + TrxSH = PrxSSPrxSH + TrxSS 
k3*PrxSSPrxSS*TrxSH*2 
 
R5: PrxSSPrxSH + TrxSH = PrxSHPrxSH + TrxSS 
k3*PrxSSPrxSH*TrxSH 
 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 =25.78 
TR = 1 
Knadph = 6 
K1trxss = 1.83 
 
 
k2 = 100 
k3 = 0.074 
 
#Species concentrations - units in µM 
 
NADPH = 200 
NADP = 1 
TrxSS = 1 
TrxSH = 1 
H2O2 = 30 
H2O = 1 
PrxSHPrxSH = 0.1667 
PrxSSPrxSH = 0.1667 
PrxSSPrxSS = 0.1667 
  
 
2.1.2 In vitro Dataset 
 
#Human peroxiredoxin 2 in vitro dataset (hprx.txt)– from 
PlotDigitizer 
 
# "[hTrx]" "V" 
 
0.18518007 0.001532415  
0.8454714 0.021095108  
1.1396866 0.02812719  
1.4713523 0.03454971  
1.7673641 0.03761227  
2.100412 0.04098131  
2.395318 0.046486653  
2.7654018 0.05016218  
3.3959813 0.053234957  
4.6558967 0.062128637  
6.582322 0.07684436  
9.81634 0.07724846  
  
 
2.1.3 Data Fitting Scripts 
 
#Fitting of the models to the human peroxiredoxin 2 in vitro 
dataset 
#using Python Notebook 
 
%pylab inline 
import scipy as sp 
import os 









pylab.rc('xtick', labelsize = 12) 
pylab.rc('ytick', labelsize = 12) 
pylab.rc('ytick.major', pad = 12) 
pylab.rc('ytick.minor', pad = 12) 
pylab.rc('axes', labelsize = 12) 
 




from matplotlib.pyplot import* 
#from numpy import arange 
matplotlib.rcParams.update({'font.size':12}) 
 
#from matplot lib get everything (*) 
from matplotlib.pyplot import * 
 
#Ping-pong enzyme model fitting 
 
fd = numpy.loadtxt('hprx.txt') 
 
m=pysces.model('hprxping') 
m.TrxSH_init = 0.01 











# generate model data for fit conditions 
def genmodeldata(xrange, kcat1, kcat2, K1h2o2): 
 
    m.kcat1 = kcat1 
    m.kcat2 = kcat2 
    m.K1h2o2 = K1h2o2 
     
    m.scan_in = 'TrxSH_init' 
    m.scan_out = ['J_R1'] 
    m.Scan1(xrange) 
    return m.scan_res[:,1] 
 
#using curve_fit 
def fitexp(expdata, p0): 
    df = len(expdata)-len(p0) 
    ydata = expdata[:,1] 
    xdata = expdata[:,0] 
    SStot = sum((ydata - np.mean(ydata))**2)   # sum of 
squares of distance of data from mean 
    cfit = sp.optimize.curve_fit(genmodeldata, xdata, ydata, 
p0, full_output=1) 
    pfit = cfit[0] 
    cov_x = cfit[1] 
    fin_residuals = cfit[2]['fvec'] 
    SSQ = sum((fin_residuals)**2) 
    SE = np.sqrt(np.diag(cov_x)) 
    SD = np.sqrt(SSQ/len(fin_residuals)) 
    Rsq = 1.0-SSQ/SStot 
    return {'pfit':pfit, 'SE':SE, 'SSQ':SSQ, 'SD':SD, 
'Rsq':Rsq, 'df':df, 'cov_x':cov_x, 'cfit':cfit} 
p0 = np.copy(( m.kcat1, m.kcat2, m.K1h2o2 )) 
curvefit = fitexp(fd, p0) 
print "parameters:\t", curvefit['pfit'] 
print "errors:\t\t", curvefit['SE'] 
print "SD:\t\t", curvefit['SD'] 
print "Rsquared:\t", curvefit['Rsq'] 
 
def plotfit(expdata, p0, label): 
    curvefit = fitexp(expdata, p0) 
    params =  curvefit['pfit'] 
    err = curvefit['SE'] 
    exp_x = expdata[:,0] 
    exp_y = expdata[:,1] 
    model_x = np.linspace(1, exp_x[-1], 100)  
    model_y = genmodeldata(model_x, *params) 
    plt.plot(exp_x, exp_y, 'o',label=label) 
    plt.plot(model_x, model_y, '-',label='model') 
    plt.xlabel('[Trx] ($\mu$M)') 
    plt.ylabel('Rate ($\mu$M.s$^{-1}$)') 
    plt.legend(loc='best') 
 
    plt.xlim(0,1.05*exp_x[-1]) 
    print "parameters:" 
    print 'kcat1:  ', curvefit['pfit'][0], ' +- ', 
curvefit['SE'][0]  
    print 'kcat2:  ', curvefit['pfit'][1], ' +- ', 
curvefit['SE'][1] 
    print 'k1h2o2 : ', curvefit['pfit'][2], ' +- ', 
curvefit['SE'][2] 
    print 'Rsquared:', curvefit['Rsq'] 
     
    





# Redox couple monomer model fitting 
 
n=pysces.model('hprxredox') 
n.TrxSH_init = 0.01 










# generate model data for fit conditions 
def genmodeldata(xrange, kcat1, k2, k3): 
     
    n.kcat1 = kcat1 
    n.k2 = k2 
    n.k3 = k3 
     
    n.scan_in = 'TrxSH_init' 
    n.scan_out = ['J_R1'] 
    n.Scan1(xrange) 
    return n.scan_res[:,1] 
 
#using curve_fit 
def fitexp(expdata, p0): 
    df = len(expdata)-len(p0) 
    ydata = expdata[:,1] 
    xdata = expdata[:,0] 
    SStot = sum((ydata - np.mean(ydata))**2)   # sum of 
squares of distance of data from mean 
    cfit = sp.optimize.curve_fit(genmodeldata, xdata, ydata, 
p0, full_output=1) 
 
    pfit = cfit[0] 
    cov_x = cfit[1] 
    fin_residuals = cfit[2]['fvec'] 
    SSQ = sum((fin_residuals)**2) 
    SE = np.sqrt(np.diag(cov_x)) 
    SD = np.sqrt(SSQ/len(fin_residuals)) 
    Rsq = 1.0-SSQ/SStot 
    return {'pfit':pfit, 'SE':SE, 'SSQ':SSQ, 'SD':SD, 
'Rsq':Rsq, 'df':df, 'cov_x':cov_x, 'cfit':cfit} 
p0 = np.copy((n.kcat1, n.k2, n.k3 )) 
curvefit = fitexp(fd,p0) 
print "parameters:\t", curvefit['pfit'] 
print "errors:\t\t", curvefit['SE'] 
print "SD:\t\t", curvefit['SD'] 
print "Rsquared:\t", curvefit['Rsq'] 
 
def plotfit(expdata, p0, label): 
    curvefit = fitexp(expdata, p0) 
    params =  curvefit['pfit'] 
    err = curvefit['SE'] 
    exp_x = expdata[:,0] 
    exp_y = expdata[:,1] 
    model_x = np.linspace(1, exp_x[-1], 100)  
    model_y = genmodeldata(model_x, *params) 
    plt.plot(exp_x, exp_y, 'o',label=label) 
    plt.plot(model_x, model_y, '-',label='model') 
    plt.xlabel('[Trx] ($\mu$M)') 
    plt.ylabel('Rate ($\mu$M.s$^{-1}$)') 
    plt.legend(loc='best') 
    plt.xlim(0,1.05*exp_x[-1]) 
    print "parameters:" 
    print 'kcat1: ', curvefit['pfit'][0], ' +- ', 
curvefit['SE'][0] 
    print 'k2:      ', curvefit['pfit'][1], ' +- ', 
curvefit['SE'][1] 
    print 'k3:  ', curvefit['pfit'][2], ' +- ', 
curvefit['SE'][2] 
    print 'Rsquared:', curvefit['Rsq'] 
     
    
plotfit(fd, p0, 'hprx')   
print '----------------------------------' 
 
#Redox couple homodimer model fitting 
 
o=pysces.model('hprxdimer') 
o.TrxSH_init = 0.01 











# generate model data for fit conditions 
def genmodeldata(xrange, kcat1, k2, k3): 
     
    o.kcat1 = kcat1 
    o.k2 = k2 
    o.k3 = k3 
     
    o.scan_in = 'TrxSH_init' 
    o.scan_out = ['J_R1'] 
    o.Scan1(xrange) 
    return o.scan_res[:,1] 
 
#using curve_fit 
def fitexp(expdata, p0): 
    df = len(expdata)-len(p0) 
    ydata = expdata[:,1] 
    xdata = expdata[:,0] 
    SStot = sum((ydata - np.mean(ydata))**2)   # sum of 
squares of distance of data from mean 
    cfit = sp.optimize.curve_fit(genmodeldata, xdata, ydata, 
p0, full_output=1) 
    pfit = cfit[0] 
    cov_x = cfit[1] 
    fin_residuals = cfit[2]['fvec'] 
    SSQ = sum((fin_residuals)**2) 
    SE = np.sqrt(np.diag(cov_x)) 
    SD = np.sqrt(SSQ/len(fin_residuals)) 
    Rsq = 1.0-SSQ/SStot 
    return {'pfit':pfit, 'SE':SE, 'SSQ':SSQ, 'SD':SD, 
'Rsq':Rsq, 'df':df, 'cov_x':cov_x, 'cfit':cfit} 
p0 = np.copy((o.kcat1, o.k2, o.k3 )) 
curvefit = fitexp(fd,p0) 
print "parameters:\t", curvefit['pfit'] 
print "errors:\t\t", curvefit['SE'] 
print "SD:\t\t", curvefit['SD'] 
print "Rsquared:\t", curvefit['Rsq'] 
 
def plotfit(expdata, p0, label): 
    curvefit = fitexp(expdata, p0) 
    params =  curvefit['pfit'] 
    err = curvefit['SE'] 
    exp_x = expdata[:,0] 
    exp_y = expdata[:,1] 
    model_x = np.linspace(1, exp_x[-1], 100)  
    model_y = genmodeldata(model_x, *params) 
 
    plt.plot(exp_x, exp_y, 'o',label=label) 
    plt.plot(model_x, model_y, '-',label='model') 
    plt.xlabel('[Trx] ($\mu$M)') 
    plt.ylabel('Rate ($\mu$M.s$^{-1}$)') 
    plt.legend(loc='best') 
    plt.xlim(0,1.05*exp_x[-1]) 
    print "parameters:" 
    print 'kcat1: ', curvefit['pfit'][0], ' +- ', 
curvefit['SE'][0] 
    print 'k2:      ', curvefit['pfit'][1], ' +- ', 
curvefit['SE'][1] 
    print 'k3:  ', curvefit['pfit'][2], ' +- ', 
curvefit['SE'][2] 
    print 'Rsquared:', curvefit['Rsq'] 
    




2.1.4 Flux Control Analysis 
#Flux control analysis of the human peroxiredoxin 2 activity 
models 
 
#import the operating system 
import os 
#tell opertaing system get the current working directory (cwd) 
and call the cwd backupdir 
backupdir = os.getcwd() 










pylab.rc('xtick', labelsize = 12) 
pylab.rc('ytick', labelsize = 12) 
pylab.rc('ytick.major', pad = 12) 
pylab.rc('ytick.minor', pad = 12) 
pylab.rc('axes', labelsize = 12) 
 
#tell opertaing system to work in the current directory 
os.chdir(backupdir) 
 
#need to call the plotting programme called matplotlib and 
pylab. 
#from pylab get stuff to doplotting 





from matplotlib.pyplot import* 
#from numpy import arange 
matplotlib.rcParams.update({'font.size':12}) 
 
#from matplot lib get everything (*) 
from matplotlib.pyplot import *  
 



















c = o.scan_res  
 


















c = o.scan_res 
  
 
Table S1 Comparison of flux control coefficients for each reaction in the peroxiredoxin 
activity models fitted to the human peroxiredoxin 2 dataset. 
Reactions Flux Control Coefficients 
 Ping-Pong Enzyme Model 
1 
𝐶𝑅1
𝐽𝑅1 = 0.232 
𝐶𝑅2





𝐽𝑅2 = 0.768 
 Redox Couple Monomer Model 
1 
𝐶𝑅1
𝐽𝑅1 = 0.232 
𝐶𝑅2
𝐽𝑅1 = 0.313 
𝐶𝑅3






















































𝐽𝑅4 = 0.733 
𝐶𝑅2
𝐽𝑅4 = 0.001 
𝐶𝑅3
𝐽𝑅4 = 0.060 
𝐶𝑅4
















2.2 Caulobacter crescentus peroxiredoxin 
2.2.1 Model Files 
 
#Realistic modelling - C. crescentus periplasmic peroxiredoxin 
 
#Ping-pong enzyme model  
 
FIX: NADPH NADP H2O2 H2O 
 








#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 = 22.75 
TR = 0.5 
Knadph = 1.2 
K1trxss = 2.8 
 
kcat2 = 73 
Prx = 0.5 
Ktrxsh = 24 
K1h2o2 = 106 
 
#Species concentrations - units in µM 
 
NADPH = 100 
NADP = 1 
TrxSS = 4 
TrxSH = 4 
H2O2 = 150 
H2O = 1  
  
 
#Realistic modelling - C. crescentus periplasmic peroxiredoxin 
#Redox couple monomer enzyme model  
 
FIX: NADPH NADP H2O2 H2O 
 




R2: H2O2 + PrxSH = H2O + PrxSS 
k2*H2O2*PrxSH 
 
R3: PrxSS + TrxSH = PrxSH + TrxSS 
k3*PrxSS*TrxSH 
 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 = 22.75  
TR = 0.5 
Knadph = 1.2 
K1trxss = 2.8 
 
k2 = 0.74 
 
k3 = 3 
 
 
#Species concentrations - units in µM 
 
 
NADPH = 100 
NADP = 1 
TrxSS = 4 
TrxSH = 4 
H2O2 = 30 
H2O = 1 
PrxSH = 0.25 
PrxSS = 0.25 
  
 
#Realistic modelling - C. crescentus periplasmic peroxiredoxin 
#Redox couple homodimer model  
 
FIX: NADPH NADP H2O2 H2O 
 




R2: PrxSHPrxSH + H2O2 = PrxSSPrxSH + H2O 
k2*PrxSHPrxSH*H2O2*2 
 
R3: PrxSSPrxSH + H2O2 = PrxSSPrxSS + H2O 
k2*PrxSSPrxSH*H2O2 
 
R4: PrxSSPrxSS + TrxSH = PrxSSPrxSH + TrxSS 
k3*PrxSSPrxSS*TrxSH*2 
 
R5: PrxSSPrxSH + TrxSH = PrxSHPrxSH + TrxSS 
k3*PrxSSPrxSH*TrxSH 
 
#Kinetic Parameters = units in µM, s-1 and µM-1 s-1 
 
kcat1 = 22.75  
TR = 0.5 
Knadph = 1.2 
K1trxss = 2.8  
 
 
k2 = 0.74 
k3 = 3 
 
#Species concentrations - units in µM 
 
NADPH = 100 
NADP = 1 
TrxSS = 4 
TrxSH = 4 
H2O2 = 30 
H2O = 1 
PrxSHPrxSH = 0.167 
PrxSSPrxSH = 0.167 
PrxSSPrxSS = 0.167 
  
 
2.2.2 In vitro Dataset 
 
# C. crescentus periplasmic peroxiredoxin dataset(pprx.txt)– 
from #PlotDigitizer 
 





102.45166 0.148446217  
201.31421 0.169207383 
300.43314 0.222976167   
500.51273 0.233225883 
752.8099 0.278175333 
1002.9143 0.269272517   
 
2.2.3  Data Fitting Scripts 
 
#Fitting of the models to the C. crescentus periplasmic 
peroxiredoxin #in vitro dataset 
 
#using Python Notebook 
 
%pylab inline 
import scipy as sp 
import os 








pylab.rc('xtick', labelsize = 12) 
pylab.rc('ytick', labelsize = 12) 
pylab.rc('ytick.major', pad = 12) 
pylab.rc('ytick.minor', pad = 12) 
pylab.rc('axes', labelsize = 12) 
 




from matplotlib.pyplot import* 
#from numpy import arange 
matplotlib.rcParams.update({'font.size':12}) 
 
#from matplot lib get everything (*) 
from matplotlib.pyplot import *  
 
fd = numpy.loadtxt('pprx.txt')  
 













# generate model data for fit conditions 
def genmodeldata(xrange, kcat2, Ktrxsh): 
 
     
    m.kcat2 = kcat2 
    m.Ktrxsh = Ktrxsh 
     
    m.scan_in = 'H2O2' 
    m.scan_out = ['J_R1'] 
    m.Scan1(xrange) 
    return m.scan_res[:,1]  
#using curve_fit 
def fitexp(expdata, p0): 
    df = len(expdata)-len(p0) 
    ydata = expdata[:,1] 
    xdata = expdata[:,0] 
    SStot = sum((ydata - np.mean(ydata))**2)   # sum of 
squares of distance of data from mean 
    cfit = sp.optimize.curve_fit(genmodeldata, xdata, ydata, 
p0, full_output=1) 
    pfit = cfit[0] 
    cov_x = cfit[1] 
    fin_residuals = cfit[2]['fvec'] 
    SSQ = sum((fin_residuals)**2) 
    SE = np.sqrt(np.diag(cov_x)) 
    SD = np.sqrt(SSQ/len(fin_residuals)) 
    Rsq = 1.0-SSQ/SStot 
    return {'pfit':pfit, 'SE':SE, 'SSQ':SSQ, 'SD':SD, 
'Rsq':Rsq, 'df':df, 'cov_x':cov_x, 'cfit':cfit} 
 
p0 = np.copy(( m.kcat2, m.Ktrxsh )) 
curvefit = fitexp(fd, p0) 
print "parameters:\t", curvefit['pfit'] 
print "errors:\t\t", curvefit['SE'] 
print "SD:\t\t", curvefit['SD'] 
print "Rsquared:\t", curvefit['Rsq']  
def plotfit(expdata, p0, label): 
    curvefit = fitexp(expdata, p0) 
    params =  curvefit['pfit'] 
    err = curvefit['SE'] 
    exp_x = expdata[:,0] 
    exp_y = expdata[:,1] 
    model_x = np.linspace(1, exp_x[-1], 100)  
    model_y = genmodeldata(model_x, *params) 
    plt.plot(exp_x, exp_y, 'o',label=label) 
    plt.plot(model_x, model_y, '-',label='model') 
    plt.xlabel('[Hydrogen Peroxide] ($\mu$M)') 
    plt.ylabel('Rate ($\mu$M.s$^{-1}$)') 
    plt.legend(loc='best') 
    plt.xlim(0,1.05*exp_x[-1]) 
    print "parameters:" 
 
    print 'kcat2:  ', curvefit['pfit'][0], ' +- ', 
curvefit['SE'][0] 
    print 'ktrxsh:  ', curvefit['pfit'][1], ' +- ', 
curvefit['SE'][1]    
    print 'Rsquared:', curvefit['Rsq'] 
     
    
plotfit( fd, p0, 'pprx')   
print '----------------------------------'  
 












# generate model data for fit conditions 
def genmodeldata(xrange, k2,  k3): 
     
    n.k2 = k2 
    n.k3 = k3 
     
    n.scan_in = 'H2O2' 
    n.scan_out = ['J_R1'] 
    n.Scan1(xrange) 
    return n.scan_res[:,1] 
 
#using curve_fit 
def fitexp(expdata, p0): 
    df = len(expdata)-len(p0) 
    ydata = expdata[:,1] 
    xdata = expdata[:,0] 
    SStot = sum((ydata - np.mean(ydata))**2)   # sum of 
squares of distance of data from mean 
    cfit = sp.optimize.curve_fit(genmodeldata, xdata, ydata, 
p0, full_output=1) 
    pfit = cfit[0] 
    cov_x = cfit[1] 
    fin_residuals = cfit[2]['fvec'] 
    SSQ = sum((fin_residuals)**2) 
    SE = np.sqrt(np.diag(cov_x)) 
    SD = np.sqrt(SSQ/len(fin_residuals)) 
    Rsq = 1.0-SSQ/SStot 
    return {'pfit':pfit, 'SE':SE, 'SSQ':SSQ, 'SD':SD, 
'Rsq':Rsq, 'df':df, 'cov_x':cov_x, 'cfit':cfit} 
 
p0 = np.copy((n.k2, n.k3 )) 
curvefit = fitexp(fd,p0) 
print "parameters:\t", curvefit['pfit'] 
print "errors:\t\t", curvefit['SE'] 
print "SD:\t\t", curvefit['SD'] 
print "Rsquared:\t", curvefit['Rsq'] 
 
def plotfit(expdata, p0, label): 
    curvefit = fitexp(expdata, p0) 
    params =  curvefit['pfit'] 
    err = curvefit['SE'] 
    exp_x = expdata[:,0] 
    exp_y = expdata[:,1] 
    model_x = np.linspace(1, exp_x[-1], 100)  
    model_y = genmodeldata(model_x, *params) 
    plt.plot(exp_x, exp_y, 'o',label=label) 
    plt.plot(model_x, model_y, '-',label='model') 
    plt.xlabel('[Hydrogen Peroxide] ($\mu$M)') 
    plt.ylabel('Rate ($\mu$M.s$^{-1}$)') 
    plt.legend(loc='best') 
    plt.xlim(0,1.05*exp_x[-1]) 
    print "parameters:" 
    print 'k2: ', curvefit['pfit'][0], ' +- ', 
curvefit['SE'][0] 
    print 'k3:  ', curvefit['pfit'][1], ' +- ', 
curvefit['SE'][1] 
    print 'Rsquared:', curvefit['Rsq'] 
     
    
plotfit(fd, p0, 'pprx)   
print '----------------------------------' 
 












# generate model data for fit conditions 
def genmodeldata(xrange, k2, k3): 
     
    o.k2 = k2 
    o.k3 = k3 
     
    o.scan_in = 'H2O2' 
 
    o.scan_out = ['J_R1'] 
    o.Scan1(xrange) 
    return o.scan_res[:,1] 
 
#using curve_fit 
def fitexp(expdata, p0): 
    df = len(expdata)-len(p0) 
    ydata = expdata[:,1] 
    xdata = expdata[:,0] 
    SStot = sum((ydata - np.mean(ydata))**2)   # sum of 
squares of distance of data from mean 
    cfit = sp.optimize.curve_fit(genmodeldata, xdata, ydata, 
p0, full_output=1) 
    pfit = cfit[0] 
    cov_x = cfit[1] 
    fin_residuals = cfit[2]['fvec'] 
    SSQ = sum((fin_residuals)**2) 
    SE = np.sqrt(np.diag(cov_x)) 
    SD = np.sqrt(SSQ/len(fin_residuals)) 
    Rsq = 1.0-SSQ/SStot 
    return {'pfit':pfit, 'SE':SE, 'SSQ':SSQ, 'SD':SD, 
'Rsq':Rsq, 'df':df, 'cov_x':cov_x, 'cfit':cfit} 
p0 = np.copy((o.k2, o.k3 )) 
curvefit = fitexp(fd,p0) 
print "parameters:\t", curvefit['pfit'] 
print "errors:\t\t", curvefit['SE'] 
print "SD:\t\t", curvefit['SD'] 
print "Rsquared:\t", curvefit['Rsq'] 
def plotfit(expdata, p0, label): 
    curvefit = fitexp(expdata, p0) 
    params =  curvefit['pfit'] 
    err = curvefit['SE'] 
    exp_x = expdata[:,0] 
    exp_y = expdata[:,1] 
    model_x = np.linspace(1, exp_x[-1], 100)  
    model_y = genmodeldata(model_x, *params) 
    plt.plot(exp_x, exp_y, 'o',label=label) 
    plt.plot(model_x, model_y, '-',label='model') 
    plt.xlabel('[Hydrogen Peroxide] ($\mu$M)') 
    plt.ylabel('Rate ($\mu$M.s$^{-1} 
$)') 
    plt.legend(loc='best') 
    plt.xlim(0,1.05*exp_x[-1]) 
    print "parameters:" 
    print 'k2:      ', curvefit['pfit'][0], ' +- ', 
curvefit['SE'][0] 
    print 'k3:  ', curvefit['pfit'][1], ' +- ', 
curvefit['SE'][1] 
    print 'Rsquared:', curvefit['Rsq'] 
    
plotfit(fd, p0, 'pprx)   
 
print '----------------------------------'  
 
2.2.4 Flux Control Analysis 
#Flux control analysis of the C. crescentus periplasmic 
peroxiredoxin #models 
#import the operating system 
import os 
#tell opertaing system get the current working directory (cwd) 
and call the cwd backupdir 
backupdir = os.getcwd() 










pylab.rc('xtick', labelsize = 12) 
pylab.rc('ytick', labelsize = 12) 
pylab.rc('ytick.major', pad = 12) 
pylab.rc('ytick.minor', pad = 12) 
pylab.rc('axes', labelsize = 12) 
 
#tell opertaing system to work in the current directory 
os.chdir(backupdir) 
 
#need to call the plotting programme called matplotlib and 
pylab. 
#from pylab get stuff to doplotting 





from matplotlib.pyplot import* 
#from numpy import arange 
matplotlib.rcParams.update({'font.size':12}) 
 
#from matplot lib get everything (*) 
from matplotlib.pyplot import *  
 


















c = o.scan_res  
 


















c = o.scan_res 
  
 
Table S2 Comparison of flux control coefficients for each reaction in the peroxiredoxin 
activity models with C. crescentus and E. coli peroxiredoxin parameters from the literature 
and parameters determined by data fitting to C. crescentus peroxiredoxin dataset. 
Reactions Flux Control Coefficients 
 
Ping-Pong Enzyme Model 
1 𝐶𝑅1
𝐽𝑅1 = 0.0001 
𝐶𝑅1






 Redox Couple Monomer Model 
1 
CR1
JR1 = 0.003 
𝐶𝑅2




𝐽𝑅1 = 0.003 
2 
𝐶𝑅2




𝐽𝑅1 = 0.003 
3 
𝐶𝑅2
𝐽𝑅1 = 0.413 
𝐶𝑅3
𝐽𝑅1= 0.584 
 Redox Couple Homodimer Model 
1 
𝐶𝑅1































𝐽𝑅3 = 0.343 
𝐶𝑅5
𝐽𝑅3 = -0.172 
4 
𝐶𝑅1
𝐽𝑅 = 0.001 
𝐶𝑅2
𝐽𝑅4 = 0.171 
𝐶𝑅3
𝐽𝑅4 = 0.656 
𝐶𝑅4
𝐽𝑅4 = 0.343 
𝐶𝑅5









𝐽𝑅5 = 0.341 
𝐶𝑅5
𝐽𝑅5 = 0.827 
 
2.3 Saccharomyces cerevisiae Tsa1 peroxiredoxin 
2.3.1 Model Files 
#Realistic modelling – TSA1 S. cerevisiae peroxiredoxin 
 
#Ping-pong enzyme model  
 
FIX: NADPH NADP H2O2 H2O 
 









#Kinetic Parameters = uM and s-1 
 
kcat1 = 66 
TR = 0.5 
Knadph = 1.2 
K1trxss = 4.4 
 
kcat2 = 0.31 
Ktrxsh =  25.5 
K1h2o2 = 12 
 




NADPH = 150 
NADP = 1 
TrxSS = 2.5 
TrxSH = 2.5 
H2O2 = 30 
H2O = 1 
  
 
#Realistic modelling – TSA1 S. cerevisiae peroxiredoxin 
 
#Redox couple monomer model  
 
#Yeast Peroxiredoxin Modelling 
 
#Model of the peroxiredoxin system with peroxiredoxin modelled 
as a redox couple 
 
FIX: NADPH NADP H2O2 H2O 
 




R2: H2O2 + PrxSH = H2O + PrxSS 
k2*H2O2*PrxSH 
 
R3: PrxSS + TrxSH = PrxSH + TrxSS 
k3*PrxSS*TrxSH 
 
#Kinetic Parameters = uM and min 
 
kcat1 = 66 
TR = 0.5 
Knadph = 1.2 
K1trxss = 4.4 
 
#approximated by kcat/km 
 
k2 = 22 




NADPH = 150 
NADP = 1 
TrxSS = 2.5 
TrxSH = 2.5 
H2O2 = 30 
H2O = 1 
PrxSH = 0.5 





#Realistic modelling – TSA1 S. cerevisiae peroxiredoxin 
 
#Redox couple homodimer model  
 
#Yeast Peroxiredoxin Modelling 
 
#Model of the peroxiredoxin system with peroxiredoxin modeled 
as a homodimer redox couple 
 
FIX: NADPH NADP H2O2 H2O 
 




R2: PrxSHPrxSH + H2O2 = PrxSSPrxSH + H2O 
k2*PrxSHPrxSH*H2O2*2 
 
R3: PrxSSPrxSH + H2O2 = PrxSSPrxSS + H2O 
k2*PrxSSPrxSH*H2O2 
 
R4: PrxSSPrxSS + TrxSH = PrxSSPrxSH + TrxSS 
k3*PrxSSPrxSS*TrxSH*2 
 
R5: PrxSSPrxSH + TrxSH = PrxSHPrxSH + TrxSS 
k3*PrxSSPrxSH*TrxSH 
 
#Kinetic Parameters = uM and s 
 
kcat1 = 66 
TR = 0.5 
Knadph = 1.2 
K1trxss = 4.4 
 
#approximated by kcat/km 
 
k2 = 22 





NADPH = 150 
NADP = 1 
TrxSS = 2.5 
TrxSH = 2.5 
H2O2 = 30 
H2O = 1 
PrxSHPrxSH = 0.33 
PrxSSPrxSH = 0.33 
PrxSSPrxSS = 0.34 
 
2.3.2 In vitro Datasets 
1. 150 µM NADPH, 0.5 µM thioredoxin reductase, 30 µM hydrogen peroxide in a 
reaction buffer pH 7.0 at varying thioredoxin (0-15 µM) and peroxiredoxin 1 µM 
peroxiredoxin 
 
# "[Trx]" "V" 
0  0.0051  
0.1 0.0339  
0.5 0.0457  
1 0.0694  
2.5 0.1153 
5 0.1366  
10 0.1381   
15 0.1406 
 
2. 150 µM NADPH, 0.5 µM thioredoxin reductase, 30 µM hydrogen peroxide in a 
reaction buffer pH 7.0 at varying thioredoxin (0-15 µM) and peroxiredoxin 2 µM 
peroxiredoxin 
 
# "[Trx]" "V" 
0  0.0021  








3. 150 µM NADPH, 0.5 µM thioredoxin reductase, 30 µM hydrogen peroxide in a 
reaction buffer pH 7.0 at varying thioredoxin (0-15 µM) and peroxiredoxin 0.5 µM 
peroxiredoxin 
 
# "[Trx]" "V" 
0  0.00104  












2.3.3 Blue Native Page of TSA1 
 
Figure S1 Standard curve for molecular weight sizing of native peroxiredoxin on a 
BN-PAGE 4-13% gradient gel using the molecular weight kit for non-
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